Microfluidic Devices with Engineered Micro-/Nanostructures for Cell Isolation by Wang, Shunqiang
Lehigh University
Lehigh Preserve
Theses and Dissertations
2016
Microfluidic Devices with Engineered Micro-
/Nanostructures for Cell Isolation
Shunqiang Wang
Lehigh University
Follow this and additional works at: http://preserve.lehigh.edu/etd
Part of the Mechanical Engineering Commons
This Dissertation is brought to you for free and open access by Lehigh Preserve. It has been accepted for inclusion in Theses and Dissertations by an
authorized administrator of Lehigh Preserve. For more information, please contact preserve@lehigh.edu.
Recommended Citation
Wang, Shunqiang, "Microfluidic Devices with Engineered Micro-/Nanostructures for Cell Isolation" (2016). Theses and Dissertations.
2863.
http://preserve.lehigh.edu/etd/2863
Microfluidic Devices with Engineered Micro-
/Nanostructures for Cell Isolation 
 
 
 
by 
  
 
 
Shunqiang Wang 
 
 
 
 
 
 
 
Presented to the Graduate and Research Committee 
of Lehigh University 
in Candidacy for the Degree of  
Doctor of Philosophy 
 
 
 
in 
 
Mechanical Engineering 
 
 
 
 
Lehigh University 
 
May 2016
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2016 Copyright 
Shunqiang Wang 
  
iii 
 
 
 
Approved and recommended for acceptance as a dissertation in partial fulfillment 
of the requirements for the degree of Doctor of Philosophy in Mechanical Engineering 
and Mechanics. 
 
Student: Shunqiang Wang 
 
Dissertation Title: Microfluidic Devices with Engineered Micro-/Nanostructures for Cell 
Isolation 
 
 
______________________  
Date     
     
    ________________________________________________    
     
Yaling Liu, Dissertation Advisor and Committee Chairman 
 
______________________  
Accepted Date         
Committee Members:  
 
 
 
_______________________ 
 
 Alparslan Oztekin 
 
           
  
________________________   
 
Donald Rockwell 
 
 
 
 _______________________  
 
Xiaohui (Frank) Zhang  
 
 
 
 _______________________  
 
Xuanhong Cheng 
iv 
 
Acknowledgements 
It was an interesting journey to pursue a Ph.D. degree in Prof. Yaling Liu's group 
at Lehigh University. This dissertation would not have been completed without supports 
from my professors, peer friends and my family. 
First and foremost, I would like to give my sincere thanks to my advisor, Prof. 
Yaling Liu. It was Prof. Yaling Liu who provided me the chance to experience such a 
meaningful and fruitful journey at such a beautiful and prestigious university. He held me 
to a high standard whiles allowed for lots of freedom on the project selection to capitalize 
on my strength. I was also always inspired by his accurate foresight on searching for 
topics which was not only scientifically comprehensive, but practically meaningful. I 
would like to thanks again for his endless and continuous supports on my career. 
I would also like to acknowledge all of my Ph.D. committee members, Prof. 
Xuanhong Cheng, Prof. Alparslan Oztekin, Prof. Donald Rockwell and Prof. Xiaohui 
(Frank) Zhang. Without all of your insightful guidance and suggestions, my dissertation 
would not have been finished to this standard. My special thanks go to Prof. Xuanhong 
Cheng who guided me through a couple projects. Besides research, she also mentored me 
and provided lots of critical suggestions on my future career. 
Thanks to all of my collaborators, who made the success of these projects possible. 
Particularly, I would like to thank Prof. Shu Yang at University of Pennsylvania, who 
provided a tremendous guidance on materials through all projects. Thanks to Dr. Elaine 
Lee and Dr. Younghyun Cho who helped me a lot in fabricating complex 
micro/nanopatterns. Their expertise in materials was also greatly appreciated. I would 
v 
 
also like to thank Dr. Yuan Wan, whose expertise in bio-nanomaterials was appreciated. 
Beyond research, I also appreciate his reference on an internship in China. Great thanks 
also go to Prof. Susan Perry, who generously allowed me to use her lab for cell culture 
and microscopy usage. Without this, the dissertation would have been much more 
delayed. 
To my peer colleagues and friends at Lehigh University, I really enjoyed the time 
to be together with you and will never forget it. Thanks for the tremendous happiness 
brought by a group of Chinese male labmates including Dr. Jifu Tan, Ran He and Wentao 
Shi. Thanks for all the great time to be together with other labmates including Dr. Antony 
Thomas, Jia Hu, Yihua Zhou, Christopher Uhl, Doruk Yunus and Salman Sohrabi. You 
guys were amazing and thanks for all of the help. Outside of the lab, I was lucky enough 
to make friends with a sea of talented students, such as Wei Zhang, Yu Song, Dr. Pengda 
Hong, Hao Wu, Yao Zhang, Yongyang Huang, Han Han, Jiangfan Zhang, Xuanxuan Lv, 
etc. My special thanks also go to my girlfriend, Yiwei Feng, who also sets a high 
standard for me which stimulates me to work hard for our future. Her endless support was 
crucial for me to finish this journey. 
Last but not least, I would like to dedicate this dissertation to my family including 
my beloved parents, Zhiming Wang and Yueping Ye, and my beloved elder brother, 
Jianshun Wang. Although without very high education, my parents knew the strength of 
knowledge and provided endless love to support both my brother and me to pursue 
doctoral degrees. They were open minded which allows us to follow our own heart over 
the course of the life journey. I would like to thank my brother who continuously 
vi 
 
supported me and helped me when confronted with any difficulties.  Thanks for taking 
care of our parents while I could hardly reach them abroad.  
  
vii 
 
 
Contents 
List of Tables .................................................................................................................................... x 
List of Figures .................................................................................................................................. xi 
Abstract ............................................................................................................................................ 1 
Chapter 1: Introduction ............................................................................................................. 3 
1.1 Background and Motivation ............................................................................................ 3 
1.2 Identification of Circulating Tumor Cells and Other Normal Blood Cells ........................ 5 
1.3 Advancing Tumor Cell Isolation using Micro-/Nanotechnologies ................................... 6 
1.4 Limitations of Current Technologies and Research Objectives ....................................... 8 
1.5 Dissertation Layout ........................................................................................................ 10 
Chapter 2: Wavy-HB CTC Chip ................................................................................................. 11 
2.1 Introduction ................................................................................................................... 11 
2.2 Method and Materials ................................................................................................... 14 
2.2.1 Microfluidic Chip Design, Fabrication and Assembly ............................................. 14 
2.2.2 Cell Culture and Blood Preparation ....................................................................... 15 
2.2.3 Cell Capture Test and Imaging ............................................................................... 15 
2.2.4 Cell Viability Assay .................................................................................................. 17 
2.2.5 Finite Element Simulation ...................................................................................... 18 
2.3 Results and Discussions ................................................................................................. 18 
2.3.1 Working Principle ................................................................................................... 18 
2.3.2 Wavy-HB Chip Design, Fabrication and Assembly ................................................. 23 
2.3.3 Wavy-HB Performance Validation by Cell Capture Tests ....................................... 25 
2.3.4 Cell Distribution along One Pattern Period and Its Indication for Device 
Performance .......................................................................................................................... 31 
2.4 Discussion....................................................................................................................... 33 
2.5 Conclusions .................................................................................................................... 37 
Chapter 3: Geometry Optimization for Grooved-HB Chip ....................................................... 39 
3.1 Introduction ................................................................................................................... 39 
3.2 Numerical Methods ....................................................................................................... 42 
viii 
 
3.2.1 Flow domain simulation ......................................................................................... 42 
3.2.2 Cell Transport Dynamics ........................................................................................ 43 
3.2.3 Cell Capture and Adhesion Probability Integration ............................................... 45 
3.3 Experiments ................................................................................................................... 47 
3.3.1 Microfluidic Chip Design and Fabrication .............................................................. 47 
3.3.2 Surface Functionalization ....................................................................................... 47 
3.3.3 Cell Culture ............................................................................................................. 48 
3.3.4 Cell Capture Test .................................................................................................... 48 
3.4 Results and Discussion ................................................................................................... 49 
3.4.1 Numerical Model ................................................................................................... 49 
3.4.2 Geometric Optimization ........................................................................................ 53 
3.5 Conclusion ...................................................................................................................... 58 
Chapter 4: Geometric Effects of Nanopillars for CTC Capture ................................................. 59 
4.1 Introduction ................................................................................................................... 59 
4.2 Experimental Details ...................................................................................................... 62 
4.2.1 Fabrication of Silicon Wafers Covered with NPs .................................................... 62 
4.2.2 Surface Functionalization of Anti-EpCAM .............................................................. 63 
4.2.3 Cell Culture and Cell-test Sample Preparation ....................................................... 64 
4.2.4 Cell-capture Yield Test and Cell Detachment Test ................................................. 64 
4.2.5 Quantitative Analysis of Cell-capture Yield, Cell Morphology and Substrate 
Wettability ............................................................................................................................. 65 
4.2.6 Calculation of Maximum Displacement of One Individual NP ............................... 65 
4.2.7 Study of Substrate Wettability Through Cassie's Law ........................................... 66 
4.3 Results and Discussion ................................................................................................... 66 
4.3.1 Fabrication and Characterization of NP Arrays ...................................................... 66 
4.3.2 Selection Criteria for Incubation Time and Shaking Speeds .................................. 69 
4.3.3 Spacing and Diameter Effects of NPs on Cell Capture Yield and Cell Behaviors .... 71 
4.4 Conclusion ...................................................................................................................... 80 
Chapter 5: Hierarchical Micro-/Nanostructured CTC Chip ...................................................... 82 
5.1 Introduction ................................................................................................................... 82 
5.2 Method and Materials ................................................................................................... 84 
5.2.1 Fabrication and Surface Functionalization of the Hierarchical CTC Chip ............... 84 
ix 
 
5.2.2 Cell Sample Preparation and Capture Test ............................................................ 86 
5.3 Results and Discussions ................................................................................................. 87 
5.3.1 Working Mechanism .............................................................................................. 87 
5.3.2 Characterization of Hierarchical Micro/nanostructures ........................................ 89 
5.3.3 Cancer Cell Capture Test ........................................................................................ 91 
5.4 Conclusions .................................................................................................................... 96 
Chapter 6: Cancer Cell Capture and Release Assisted by Magnetic Particles in Hierarchical 
Wavy-HB Microfluidic Devices ....................................................................................................... 97 
6.1 Introduction ................................................................................................................... 97 
6.2 Experimental Details ...................................................................................................... 99 
6.2.1 Working Mechanism .............................................................................................. 99 
6.2.2 Microfluidic Chip Fabrication and Magnet Settings ............................................. 100 
6.2.3 Cancer Cell Culture, Flow Test and Re-culture ..................................................... 101 
6.3 Results and Discussions ............................................................................................... 102 
6.4 Conclusion .................................................................................................................... 109 
Chapter 7: Isolation of Rare Tumor Cells Using Adhesion Rolling in a Microfluidic Chip with 
Inclined Wavy Surfaces ................................................................................................................ 111 
7.1 Introduction ................................................................................................................. 111 
7.2 Methods ....................................................................................................................... 112 
7.2.1 Working Mechanism ............................................................................................ 112 
7.2.2 Microfluidic Chip Fabrication and Surface Functionalization .............................. 114 
7.2.3 Cell Culture and Isolation Test ............................................................................. 115 
7.3 Results .......................................................................................................................... 116 
7.4 Conclusion .................................................................................................................... 117 
Chapter 8: Summary and Outlook ......................................................................................... 119 
References: .................................................................................................................................. 125 
Vita ............................................................................................................................................... 139 
 
  
x 
 
List of Tables 
Table 1-1 Properties of CTCs and other normal blood cells...............................................6 
Table 1-2 Summary of existed techniques for isolation of CTCs.......................................8 
Table 4-1 Geometrical Properties of NP arrays. Different groups are named as "NP" 
followed by their average diameters. ................................................................................67 
  
xi 
 
 
List of Figures 
Figure 1-1 Patient blood is injected through a typical microfluidic device for CTC 
detection.............................................................................................................................4 
Figure 2-1 Illustrative flow chart of surface functionalization on PDMS........................16 
Figure 2-2 Working mechanism of the wavy-HB microfluidic chip for highly efficient 
and selective CTC capture. (a) Schematic figure of a single unit of the wavy-HB pattern. 
(b) Flow velocity components in the cross-section illustrate the micro-vortex. (c) Integral 
of cross flow over the unit for both grooved- and wavy-HB patterns. The contours of the 
shear rate in (d) wavy- and (e) corresponding grooved-HB chips. The color bar is shown 
with the unit of /s. The distortion of the images is due to cut-off of the range in order to 
make the color map clear. The rest area over the range is filled in black. (f) Theoretical 
analysis of cell-surface contact area along one period for both wave and groove patterns. 
For the groove pattern, two data points (2.31 μm2) are not shown when a cell is located in 
the intersection between the bottom and the side wall. (g) The shear rate along the arc 
length of both a groove and wave period (trough-ridge-trough: indicated by the dashed 
line in (d) and (e)) with a distance of a cell radius away from the surface. Here, the arc 
length is normalized to its period for both patterns...........................................................20 
Figure 2-3 Numerical simulation reveals the effect of the groove period on capture 
efficiency...........................................................................................................................21 
Figure 2-4 Illustrations of cell-surface contact modes on (a) wavy pattern and (b) 
grooved pattern. Plot is not in scale. (c) Total pattern surface area for one period of 
groove and wave patterns calculated based on prescribed geometries..............................22 
Figure 2-5 Illustration of the wavy-HB chip and its fabrication process. (a) Fabrication 
process of the wavy-HB master. The "level down" and "level up" are due to the 
photoresist melting. Micrograph images of (b) top view for the silicon molds (Scale bar, 
200 μm) and (d) side view for the assembled chip (Scale bar, 50 μm) illustrate the detail 
periodic designs and the wavy structures. The assembled chip was cut along the dashed 
line marked in (b) to obtain the side view. (c) and (e) sketch the layout of the wavy-HB 
structures with the detailed parameters. The red spheres stand for cells flowing in the 
channel. (f) Sample injection into a wavy-HB microfluidic device consisting of one inlet 
and one outlet. (Scale bar, 10 mm)....................................................................................24 
xii 
 
Figure 2-6  Profilometer results of the wavy pattern for three samples made by the reflow 
approach.............................................................................................................................25 
Figure 2-7 Distributions of CTCs along flow direction in (a) grooved patterns and (b) 
wavy patterns; Distribution of WBCs along flow direction in (c) grooved patterns and (d) 
wavy patterns. The microfluidic device is equally divided into parallel sections along the 
flow direction, with the first 20 sections with a width of 1.14 mm shown here. Curve 
fitting are adopted in each group to indicate the trend of the cell distribution profile......26  
Figure 2-8 Tumor cells capture in the wavy-HB and grooved-HB chips (a)-(c) Cell-
tracker and DAPI fluorescent differentiation of tumor cells and WBCs. Both tumor cells 
and WBCs are DAPI positive in (a), while only pre-labeled CTCs are cell-tracker positive 
in (b). The merged image in (c) shows only cells which are DAPI (+) and cell-tracker (+) 
are regarded as tumor cells, while cells which are DAPI (+) and cell-tracker (-) are 
regarded as WBCs. (Scale bar, 80 μm) (d) Capture efficiency vs. shear rate in the 
grooved-HB chip, the wavy-HB chip, and the flat device. (e) Purity vs. shear rate in both 
chips. Error bars stand for standard deviations in three independent experimental 
trials....................................................................................................................................28 
Figure 2-9 Viability of captured tumor cells in the wavy-HB and grooved-HB chips. 
Representative fluorescent micrographs of the captured tumor cells in the grooved-HB 
chip after LIVE/DEAD a under the shear rate of (a) 60/s and (b) 400/s. LIVE/DEAD 
stain results in the wavy-HB chip under the shear rate of (c) 60/s and (d) 400/s, 
respectively. (e) LIVE/DEAD stain results in the flat channel under the shear rate of 60/s. 
Cells which are calcein-AM (+) and EthD1 (+) are treated as dead, as indicated by white 
arrows in (a)-(e). (f) Quantitative analysis of viability of captured tumor cells in the 
wavy-HB and grooved-HB chips under different shear rates. Error bars stand for standard 
deviations in three independent experimental trials. (Scale bar, 160 μm).........................30 
Figure 2-10 Linear regression analysis of the captured cell amount versus spiked cell 
amount. HCT-116 cells at various concentrations were spiked in PBS buffer solution and 
captured cell amount were then counted. Error bars stand for standard deviations in three 
independent experimental trials.........................................................................................31 
Figure 2-11 Illustrative micrograph images of tumor cells distributions in (a) a grooved-
HB chip and (b) a wavy-HB chip. (Scale bar, 80 μm) Quantitative distributions of tumor 
cells along one pattern period in (c) the grooved-HB chip and (d) the wavy-HB chip. 
Distribution of WBCs along one pattern period in (e) the grooved-HB chip and (f) the 
wavy-HB chip. One pattern period is defined as trough-peak-trough indicated as the 
dotted line in (a) and (b). A pattern period is equally divided into 20 sections along the 
flow direction with a width of 8 μm. Schematic images of the divided patterns are also 
shown in (c)-(f). Curve fits are used to indicate the cell distribution patterns...................33 
xiii 
 
Figure 2-12 Numerical simulation reveals cell-surface contact frequency in the grooved-
HB chip and the wavy-HB chip. The locations for cell-surface interactions, including the 
pattern ridge (green), channel top (red), pattern bottom (black) and pattern side (blue) in 
(a) the grooved-HB chip and (b) the wavy-HB chip. The upstream and downstream along 
one streamline is illustrated in (a). (c) Normalized cell-surface contact frequency in 
different locations for both chips.......................................................................................35 
Figure 3-1 (a) Typical flow domain of one unit in a herringbone microfluidic chip 
simulated by COMSOL. (b) The chaotic flow pattern for enhanced cell-surface 
interactions in a cross-section. Schematic diagrams of a herringbone unit with all 
annotated geometrical parameters from (c) top view and (d) side view. A scenario of 
flowing cell to be firmly captured or not determined by adhesion probability is illustrated 
in (d)...................................................................................................................................50 
Figure 3-2 (a) A Hele-Shaw design with shear rate linearly decreasing along the flow 
direction ; (b) Normalized cell amount along the flow direction. The channel is divided 
into equal sections with a microscope window width of 1 mm. Cell amounts in 
continuous microscope windows are normalized by the average of cell amount in the last 
window section where the shear rate is the smallest. Error bars stand for standard 
derivation from five independent windows in each cross-section. An exponential curve fit 
is then applied to obtain the value of B..............................................................................51 
Figure 3-3 (a) Comparison of the ridge-bottom ratio of the captured cell amount between 
experimental and numerical results under various attempts of A ranging from 0.01 to 500. 
(b) The error calculated by the least square method under different A. The zoom-in image 
shows the optimized value for A where a smallest error exists.........................................52 
Figure 3-4 Numerical results of normalized capture amount under (a) different number of 
grooves per half cycle and (b) different groove intersection angles..................................53 
Figure 3-5 (a) Numerical results of normalized capture amount under different channel 
widths and different asymmetrical factors. (b) Numerical results of normalized capture 
amount under different channel heights and different groove depths................................55 
Figure 3-6 (a) Numerical results of normalized capture amount under different groove 
pitches and groove widths. (b) Theoretical hydraulic resistance calculated for both the 
bottom groove and the upper plain channel in a herringbone microfluidic chip with a 
groove pitch of 200 μm. The intersection point indicates a flow resistance balance 
between the groove and the plain channel.........................................................................56 
Figure 3-7 (a) Schematic diagram of a herringbone microfluidic chip from the side view. 
The channel surface is divided into four sections marked in different colors. (b) 
xiv 
 
Numerical results of cell-surface contact frequencies in different sections under different 
groove widths with a fixed groove pitch of 160 μm..........................................................57 
Figure 4-1 (a) Fabrication process of NP arrays by metal assisted chemical etching 
method. (b) A typical SEM image of NP arrays with average diameter of 650 nm from 
tilted view. The inset in (b) shows the magnification of NPs from tilted view. (c) 
Mechanical and geometrical properties of NP substrates: compliance and packing density. 
(d) A finite element method (FEM) analysis of a single bending NP showing the 
displacement of an NP with diameter of 120 nm. The unit of the color bar is nanometer. 
(e) Wettability of different NP substrates before and after functionalization. The solid line 
and dashed line stand for fitted curves using Cassie's law for non-functionalized and 
functionalized NP substrates, respectively. Error bars in (e) stand for standard derivation 
from three independent experiments..................................................................................69 
Figure 4-2 Quantitative evaluation of capture yield for cases with 1% BSA coated and 
with anti-EpCAM coated (a) at different incubation times followed by 10 minutes of 
shaking in 60 rpm and (b) after 1 hour of incubation followed by 10 minutes of shaking 
under various shaking speeds. Each error bar represents a standard derivation and is 
obtained from three independent experiments...................................................................71 
Figure. 4-3 (a) Zoomed-in and zoomed-out SEM images reveal details of microvilli on 
the cell membrane. (b)-(d) Cell behaviors in NP substrates with a spacing of 38 nm for 
NP300 in (b), 790 nm for NP650 in (c), 140 nm for NP550 in (d). All cells were 
incubated for 1 hr followed by 10 mins of shaking in 60 rpm...........................................73 
Figure 4-4 (a) Cell capture yield measured on substrates with different diameters of NPs 
after 1 hour of incubation and 10 minutes of shaking in 60 rpm. (b) Schematics (not in 
scale) of a captured cell on an NP substrate with red bold line marked as the effective 
contact area, and a typical SEM image of a captured cell on NP1100 from tilted view. (c) 
Cell morphology consisting of cell height and apparent contact area for different NP 
substrates. The inset of (c) shows apparent contact areas for NP substrates with various 
diameters and planar wafer. (d) Cell capture yield measured on NP substrates with 
various diameters and planar wafer. The inset in (d) shows effective contact areas for NP 
substrates with various diameters and planar wafer. The solid line in (d) stands for a 
linear fit. Error bars for capture yield in (a) and (d) stand for standard derivation from 
three independent experiments. Error bars in (c) stand for standard derivation from 20 
arbitrary cells' measurements.............................................................................................75 
Figure 4-5 Capture yield in terms of different apparent contact area...............................78 
Figure 4-6 Schematics of experimental setup and SEM images showing the cell-NP 
interactions (lamellipodia and filopodia) for different NP substrates. (a) A schematic of 
the experimental setup during shaking. (b) shows the corresponding locations on wafer 
xv 
 
substrates for (c)-(i), with corresponding flow directions marked in red arrows. (c)-(e) 
show cell behaviors on planar wafers with shaking speeds of 0, 60 rpm and 400 rpm, 
respectively. (f)-(i) show cell behaviors in NP120, NP200, NP 550 and NP1100 with an 
average spacing of 140 nm, respectively. Typical lamellipodia and filopodia are 
annotated in each figure. Orientations of (c)-(i) have been adjusted to be the same as that 
in (b)...................................................................................................................................80 
Figure 5-1 (a) The flow chart of NP deposition on the wavy-HB PDMS device. (b) The 
experimental setting for NP deposition. The PDMS device moves up and down following 
the needle which is controlled by the manipulator............................................................86 
Figure 5-2 (a) Concept illustration of cancer cell capture in a microfluid chip with 
hierarchical micro/nanostructures. NPs coated with anti-EpCAM are deposited on the 
wavy-HB pattern. (b) Photographic image of the test setting for the hierarchical CTC 
capture chip........................................................................................................................88 
Figure 5-3 SEM images of deposited NPs on (a) top ridge and (b) bottom trough after the 
deposition process. (c) Illustrative image of the NP convection induced by ethanol 
evaporation if exposed directly to air. More particles are thus deposited on the top ridge 
and less particles on bottom trough. Scale bar: 2 μm........................................................90 
Figure 5-4 (a) Illustrative image of the NP deposition under the (b) improved 
evaporation setting. SEM images of deposited NPs on (c) top ridge and (d) bottom trough 
after the deposition process................................................................................................90 
Figure 5-5 (a)-(d) Fluorescent images of a single cancer cell and a single WBC by using 
a cocktail solution containing DAPI, Cytokeratin-FITC and CD45-PE. (e)-(h) Fluorescent 
images of a single cancer cell and a two-cancer cell cluster by using the same cocktail 
solution...............................................................................................................................92 
Figure 5-6 (a) Capture efficiency vs. shear rate in different devices in both PBS buffer 
solution and blood. (b) Amount of non-specifically captured WBCs in 1 mL blood in 
different devices at different shear rates............................................................................94 
Figure 5-7 (a) Microscopic image of captured cancer cells on the hierarchical wavy-HB 
pattern. Scale bar: 160 μm. (b) SEM image of captured cancer cells on the pattern. Scale 
bar: 50 μm.  (c) The zoom-in image reveals details of the interaction between a cancer 
cell and the NPs covered wavy pattern. Scale bar: 8 μm...................................................95 
Figure 5-8 Particle deposition after a single flush of streptavidin coated magnetic 
microparticles in (a) a flat channel and (b) a wavy-HB chip to form a hierarchical 
micro/nanostructures. Scale bar: 100 μm...........................................................................96 
xvi 
 
Figure 6-1 Illustration of working principles of magnetic particle assisted cancer cell 
capture and release. (a) Capture of cancer cells on the anti-EpCAM coated magnetic 
particles deposited on the surface under the magnetic field. (b) Release and collection of 
captured cancer cells and magnetic particles after the removal of the magnet. (c) 
Photographic image of a typical experimental setting of cancer cell capture under the 
magnetic field...................................................................................................................100 
Figure 6-2 Various magnet settings and their corresponding magnetic particle response. 
(a)-(c) Three different magnet settings. (d-f) Response of magnetic particles under the 
magnetic field of (a-c) in 2 minutes, respectively. (g-i) Response of magnetic particles 
after PBS buffer flushing of 200/s under the magnetic field of (a-c), respectively. Scale 
bar: 250 μm. (j) Streamlines in a unit of wavy-HB patterns. Flow direction is from left to 
right..................................................................................................................................103 
Figure 6-3 Theoretical analysis of dipole-dipole induced magnetic forces. (a) Illustrative 
image of two magnetic particles to form a dipole-dipole pair under the magnetic field. (b) 
Normalized magnetic forces in the radial and tangential directions in term of intersection 
angles...............................................................................................................................105 
Figure 6-4 (a)-(c) Typical magnetic particle distributions under flushing of PBS buffer 
solution in three relative locations to the magnets in the setting of (e). Scale bar: 200 μm. 
(d) Magnetic forces from point A to point B in (f) which mimics the location of the 
microfluidic chip. (f) Contour of the magnetic field in the setting of (e)........................107 
Figure 6-5 Flow cytometer analysis of collected samples: (a) Cancer cells stained with 
cytokeratin-FITC in PBS buffer solution; (b) Whole blood and (c) Cancer cells stained 
with cytokeratin-FITC mixed with anti-EpCAM coated magnetic particles. Here, (a) and 
(b) serve as control group to identify cancer cells. Data in (c) is the experimental result 
from capture and release of cancer cells assisted by coated magnetic particles..............108 
Figure 6-6 Re-culture of collected cancer cells linked with magnetic particles and 
individual magnetic particles. (a)-(b) Cell re-culture on Day 1 and Day 4 for Passage 0, 
respectively. (c)-(d) Cell re-culture for Passage 1 and Passage 2, respectively. Scale bar: 
40 μm...............................................................................................................................109 
Figure 7-1 (a) Experimental setup for the tumor cell isolation. (b) The proposed concept 
of different cells flowing or rolling along different pathways.........................................113 
Figure 7-2 (a) The velocity contour in the cross-section of the Fig. 1(b). (b) A schematic 
image of the looped flow pattern and the forces on a flowing cell. (c) A schematic image 
indicates the interaction between cells and E-selectin coated surfaces...........................114 
xvii 
 
Figure 7-3 Optical image indicates cell focusing effect in a microfluidic chip with 
inclined patterns...............................................................................................................116 
Figure 7-4 Transient cell rolling image for (a) CTC and (b) WBC. (c) Rolling velocity 
for PC3 cells and WBCs under different shear rates and different E-selectin coating 
density..............................................................................................................................117 
 
  
1 
 
Abstract 
 Isolation of cells from blood is critical for vast biomedical applications. The focus 
of this dissertation is on the isolation of circulating tumor cells (CTCs) from patient blood, 
which contains important prognostic and diagnostic information. Challenges in this field 
originates from the striking contrast between the rare amount of CTCs (1-10 per mL) and 
vast other normal cells (millions of white blood cells (WBCs) and billions of red blood 
cells per mL). Various techniques have been developed to isolate CTCs in the recent 
decades, while the most demanding clinical requirements lie in two aspects: higher 
capture efficiency meaning the strong ability to isolate the rare CTCs and higher purity 
meaning the strong ability to repel all other normal cells. In order to better serve clinical 
practice, we developed four microfluidic platforms aiming at high capture efficiency and 
high purity, thus advancing the cancer patient care.   
 By extending the concept of the hallmark immunoaffinity based grooved-
herringbone (HB) chip, we first developed a wavy-HB chip by smoothing the grooved 
patterns to wavy patterns. The wavy-HB chip was demonstrated to not only achieve high 
capture efficiency (up to 85.0%) by micro-vortexes induced by HB structures, but 
achieve high purity (up to 39.4%) due to the smooth wavy microstructures. The HB 
structures were then further optimized through a refined computational model 
implemented with cell adhesion probability. The particulate cell transport dynamics was 
shown to be crucial in determining the optimized geometry for CTC capture. To further 
enhance the CTC capture, integration of nanostructures was examined due to their 
intrinsic large surface area-to-volume ratio. By exploring the geometric effects of 
2 
 
nanopillars on CTC capture, we unraveled an interesting linear relationship between CTC 
capture efficiency and effective nanopillar contact area. We then developed a fabrication 
approach to deposit nanoparticles on the wavy-HB patterns to form hierarchical 
micro/nanostructures. The hierarchical wavy-HB chip was demonstrated to achieve a 
capture efficiency up to ~98% and a high purity performance (only ~680 WBCs per 1 mL 
blood). 
 Over the course of the above-mentioned work, there emerges another clinical 
need which requires captured CTCs to be released and re-cultured for post-analysis such 
as drug screening. We thus developed two microfluidic chips attempting to achieve this 
goal. The first platform is an integration of immunomagnetic particles on the developed 
wavy-HB chip. In addition to the good device performance brought by the wavy-HB 
patterns, CTCs were able to be released from the capture bed by removing the magnetic 
field. The collected CTCs labeled with magnetic particles were able to be re-cultured and 
it was found that these magnetic particles were subject to self-removal during cell 
proliferations. The second platform was an inclined wavy patterns coated with E-selectin, 
which was able to form weak adhesion forces with WBCs and CTCs. A proof-of-concept 
work was performed to demonstrate that WBCs and CTCs were able to be separated 
along different pathways due to the different adhesion forces and the inclined direction 
guidance. 
 With all these developed cancer cell isolation microfluidic chips, we showed our 
contributions toward effective cancer cell isolation and eventually cancer treatment.  
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Chapter 1: Introduction 
 
1.1 Background and Motivation 
 According to the first Global Burden of Disease study, cancer is among the 
leading causes of death in both developed and developing countries [1]. Among all 
cancer deaths, Metastasis, defined as the spreading of cancer cells in the primary tumor to 
distant organs, accounts for the majority while still remains poorly understood [2]. The 
traditional method to diagnose cancer is biopsy, which studies the tissue or cell sample 
extracted from the patient [3]. However, the invasive biopsy always accompanies with 
huge pains, thus bringing lots of discomforts to patients. As an alternative approach, non-
invasive liquid biopsy which studies on patient blood sample is attracting more attention 
nowadays. 
Studies of biomarkers for different diseases have been vastly pursued. Three main 
biomarkers have been identified to effectively indicate cancer status to certain extent, 
namely, circulating tumor DNA (ctDNA), circulating microRNA (miRNA) and 
circulating tumor cells (CTCs). For instance, ctDNA was quantitatively measured to 
evaluate the tumor dynamics which can potentially help clinician make therapy decisions 
[4]. Circulating miRNA in plasma was used as an indicator to differentiate prostate 
cancer patients from healthy groups [5]. Similar to these two molecular biomarkers, 
CTCs behaviors in cellular level have also been demonstrated to act as an effective 
indicator for cancer status. Clinical studies have been pursued to support the view that 
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detection of CTCs can be achieved several years before the traditional diagnosis [6-7], 
thus providing high chances for patients to survive before severe cancer growth. 
Moreover, amount of CTCs also contains prognostic information, which has been 
demonstrated to predict overall survival rate in prostate cancer patients [8]. These 
promising results have inspired researchers to develop various techniques to isolate CTCs 
from patient blood. Notably, due to the dramatic amount difference of rare CTCs (as few 
as one in 1 ml blood) and other normal cells (millions and billions in 1 ml blood), CTC 
detection presents two main technique challenges: 1. How to achieve high CTC capture 
efficiency, meaning the ability to detect as many CTCs as possible in the blood; 2. How 
to achieve high selectivity, meaning the ability to differentiate CTCs from nucleated 
white blood cells (WBCs) and red blood cells (RBCs). 
 
Figure 1-1 Patient blood is injected through a typical microfluidic device for CTC 
detection. 
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1.2 Identification of Circulating Tumor Cells and Other 
Normal Blood Cells 
 Properties of CTCs and other normal blood cells were summarized in Table 1-1. 
Although CTCs were generally larger than WBCs, a size overlap still existed for several 
cancer cell types. So far, the most well-recognized property difference between CTCs and 
other blood cells were on the cell-specific surface biomarkers [9]. Specifically, CTCs of 
epithelial origin universally expressed epithelial cell adhesion molecules (EpCAM) 
which were absent for other blood normal cells, although recent studies revealed that 
EpCAM underwent a down-regulation through the epithelial-mesenchymal transition 
(EMT) which brought difficulty in efficiently isolating CTCs based on the anti-EpCAM 
approach [10]. On the other aspect, there also existed leukocyte common antigens such as 
CD45 and CD66b. Due to the heterogeneity of CTCs and other normal blood cells 
especially leukocytes, approaches to isolate CTCs should be carefully selected by taking 
the most significant difference into account for different applications. 
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Table 1-1 Properties of CTCs and other normal blood cells 
          Type 
 
Properties 
CTC WBC RBC Platelet 
 
 
Ref. 
 
Size* (µm) 8-25 6-14 6-8 2-3 [11-14] 
Shape Spherical Spherical Biconcave Biconvex [14-16] 
Stiffness 
(Young's 
Modulus) 
0.3-1.1kPa ~0.156 kPa 
~0.102  
kPa 
1-50 kPa 
[17-20] 
Immunoaffinity 
Epithelial 
cell surface 
markers 
such as 
EpCAM 
Leukocyte 
Common 
Antigens such as 
CD45 and CD66b 
  
[21-22] 
*Note: cell size measurements vary significantly based on the method as well as the cell 
subtypes. 
1.3 Advancing Tumor Cell Isolation using Micro-
/Nanotechnologies 
 As an emerging multi-disciplinary field, nanotechnology raised vast opportunities 
for cancer detection by interfacing biology, chemistry and engineering. The cell-
nanostructure interaction has also been reviewed comprehensively and several basic 
design principles have been delivered [23]. For the selection of nanomaterials, silicon 
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nanomaterials are good candidates for CTC study due to their biocompatibility and 
unique electronic properties [24]. Compared to flat surfaces, nanostructured substrates 
provide a larger surface area for the immobilization of anti-epithelial cell adhesion 
molecules (anti-EpCAM), increasing the binding odds between the antibody and 
membrane receptor and also total binding forces, thus enhancing the CTC isolation 
efficiency. Moreover, the natural extracellular matrix or basement membrane mimicking 
nanostructured substrates offered a suitable environment for CTC attachment [25]. 
 Similarly, the advance in microscale technologies also paves new ways for cancer 
detection. Especially, various established microfabrication approaches including soft 
lithography allow convenient convergence of multiple disciplinary components [26], 
which makes it possible to simplify tedious laboratory tests to single device test. With a 
specific interest, microfluidic in recent years has vastly applied in CTC detections, due to 
its various advantages including small sample cost, fast result-output, etc. To date, 
microfluidic devices for CTC detection mainly relies on two different regimes: physical 
properties (Size [27], density [28] and deformability [29]) or expressions of biomarkers 
[30-31], which were summarized in Table 1-2. Notably, several hallmark microfluidic 
devices have been developed by Toner’s group: three-generation CTC chips have been 
developed to achieve highly efficient CTC capture performance. A typical microfluidic 
setup for CTC capture is shown in Figure 1-1. Other CTC detection techniques have been 
intensively covered in several review papers [32-33]. 
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Table 1-2 Summary of existed techniques for isolation of CTCs 
Isolation Techniques 
(Structures or Main Mechanisms) 
Efficiency Specificity Ref. 
Immuno-affinity Microposts 65% 50% [34] 
Herringbone 
groves 
93% 14% [35] 
Size Difference Spiral channel 80% 400-680 
WBCs/mL 
[36] 
Density Difference Density gradient 
media 
70%-90%  [28] 
Dielectric 
Difference 
Slanted electrodes ~99% ~94% of WBCs 
were depleted 
[37] 
 
1.4 Limitations of Current Technologies and Research 
Objectives 
 Despite all the exciting work reported in literature, there still exist limitations for 
these technologies in regards of achieving both high capture efficiency and selectivity. 
For instance, there is a large trade-off between capture efficiency and selectivity for the 
groove-herringbone device in Toner’s work [31]. In another word, high selectivity still 
remains the main challenge towards achieving high capture efficiency. Specifically, in 
recent years, integrations of various complex geometry patterns have been proposed to 
increase CTC interactions with anti-EpCAM coated surfaces. Nagrath et al. [9] reported a 
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microfluidic chip with an array of microposts, which precisely controls the flow path to 
enhance the CTC-pillar interactions. Due to the inherent property of laminar flow pattern 
in this platform, the capture efficiency reaches its limitation of 65% in the flow rate of 1.1 
ml/hr. To overcome this limitation, approaches to disturb the laminar pattern attracts lots 
of attention from researchers. Stroock et al. [38] firstly reported a staggered herringbone 
structure to generate passive chaotic mixing. Integration of this structure into microfluidic 
chips was then widely adopted for CTC capture with significantly increased capture 
efficiency obtained [31, 39]. While high efficiency was achieved, the selectivity remained 
poor (14%) [31], likely due to the non-specific trapping of the cell at the sharp corners of 
the micro-groves. 
 To overcome these problems and advance tumor cell isolation, this dissertation 
aims to develop microfluidic devices with novel micro-/nanostructures to achieve both 
competitively high capture efficiency and selectivity when compared with the ones 
reported in literature. Specifically, the intermediate goals of this dissertation are 
described as follows: 
(a) Develop and validate a novel microfluidic chip with wavy-herringbone structures 
for highly efficient and selective isolation of tumor cells. 
(b) Optimize the geometry of herringbone structures for highly efficient isolation of 
tumor cells with an improved numerical model. 
(c) Examine the geometric effects of nanopillar height and diameter on isolation of 
tumor cells. 
(d) Develop and validate a novel microfluidic chip with hierarchical micro-
/nanostructures for highly efficient and selective isolation of tumor cells 
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(e) Make a few attempts to develop novel microfluidic chips which are capable to 
directly isolate CTCs in free suspension 
1.5  Dissertation Layout 
 This dissertation is organized following the roadmap described below. Chapter 2 
will discuss the development and prototype of a novel microfluidic chip with wavy-
herringbone structures for tumor cell isolation. Both computational prediction and 
experimental validation will be used to demonstrate the functionality of the proposed chip. 
Then an improved computational model will be developed and used to optimize the 
herringbone structures for most efficient tumor cell isolation in Chapter 3. To further 
improve the tumor cell isolation, nanostructures will be implemented to the developed 
wavy-herringbone chip. To find the optimized nanostructure geometry, geometric effects 
of nanopillar height and diameter on tumor cell capture will be examined and geometric 
guides on nanostructures will also be determined in Chapter 4. By taking the advantages 
of both micro- and nano-structures in regards of tumor cell isolation, Chapter 5 will 
discuss the development and prototype of an improved microfluidic chip with 
hierarchical micro-/nanostructures for better tumor cell isolation. In Chapter 6 and 
Chapter 7, two attempts will be discussed to directly isolate CTCs in free suspensions. 
Lastly, Chapter 8 will present a summary of the dissertation and indications for future 
work. 
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Chapter 2: Wavy-HB CTC Chip 
 
2.1 Introduction 
 In the past few decades, microfluidic devices have been extensively employed in 
the fields of chemical, biomedical and environmental engineering, summarized in a few 
review articles [40-42]. The device miniaturization using microfluidics leads to low 
reagent cost, low waste, fast reaction process and the predictable laminar flow pattern in 
microscale fluid flow [41, 43-45]. One exciting application is the early-stage detection of 
circulating tumor cells (CTCs) [34, 46], which are rare cells originally shed from a solid 
primary tumor and ultimately form a secondary tumor site in the course of blood 
circulation. Increasing studies have also shown strong clinical relevance of CTC amount 
for early cancer diagnostics [47], metastasis progress [7, 48] and therapy response [49-
50]. In various common cancers, including breast cancer, pancreatic cancer and colorectal 
cancer, CTCs have been found to overexpress epithelial cell adhesion molecules 
(EpCAMs), which are not found in normal cells. Given the EpCAM expression 
difference, researchers have designed various microfluidic channels coated with anti-
EpCAM for immuno-affinity based CTC detections [34, 51-53]. However, the challenge 
still lies in the efficiency of detection due to the scarce amount of CTCs, typically 1-10 
cells vs. 4 billion red blood cells (RBCs) and 4 million white blood cells (WBCs) per 1 
mL of patient blood. The typical laminar flow in a microfluidic device will not be able to 
address the challenge, especially for limited time and channel length. 
Passive mixing within microfluidic devices has been proposed to induce increased 
collisions between cells and anti-EpCAM coated channel surfaces, thus enhancing the 
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cell capture [54-55]. One hallmark micro-mixer, first introduced by Stroock et al. [56], is 
the staggered grooved-herringbone (HB) mixer. The asymmetric grooved-HB structures 
stretch and fold the flows in the cross-section, yielding chaotic flows that are essential for 
generating efficient mixing. By adopting this principle, Stott et al. [35] developed a HB-
chip for high-throughput and efficient CTC capture, where in-vitro clinical utilities have 
been demonstrated with a capture efficiency of up to 79% under low shear rates of ~13/s. 
The cell dynamics in the micro-vortex flow induced by grooved-HB structures have also 
been studied extensively [57-58], which provide design guidelines for specific 
applications. Moreover, the structure simplicity of the grooved-HB structure allows for 
its wide integration into various platforms to enhance the cell-surface interactions. Wang 
et al. [54] integrated grooved-HB structures on the top of nanostructured substrates, 
where the chaotic effect induced by grooved-HB dramatically enhanced the CTC capture 
performance with capture efficiency of up to 95% at a flow rate of 0.5 mL/h. Similar 
enhancements have been demonstrated in the NanoVelcro chip developed by Tseng’s 
group [59-60] and CTC chips developed by Fan’s group [55, 61].  
Besides capture efficiency, purity should also be taken into consideration when 
evaluating the performance of a CTC capture device. Purity is the ability to resist non-
specific capture of WBCs, and is normally defined as the ratio of the number of captured 
CTCs to the total number of captured cells. It is highly desired to achieve both high 
capture efficiency and high purity [32]. Yet, the trade-off between CTC capture 
efficiency and purity remains a universal problem for existing microfluidic platforms. In 
general, cell adhesion probability on a surface decreases with increased shear rate [62-63], 
which applies to both CTCs and WBCs. In another word, higher CTC capture efficiency 
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is normally achieved under lower shear rate, under which WBCs tend to be non-
specifically captured, resulting in a relatively low purity. This is especially true for the 
grooved-HB microfluidic chip, where trough regions with ultra-low shear rate (as shown 
in Figure 2-1(e)) have a high chance to trap WBCs. As a result, although high capture 
efficiency up to 79% was obtained in grooved-HB device, the purity was sacrificed down 
to 14% [35]. One strategy to improve purity is to eliminate the low shear sharp corners, 
which are prone to non-specific binding for WBCs while keeping the chaotic effect 
provided by HB structures. Here, we fabricated a microfluidic chip integrated with wavy-
HB structures (Figure 2-1(a)), where the smooth waves are expected to allow for smooth 
shear rate transitions and eliminate the ultra-low shear rate regions. In vitro tests with 
whole blood spiked with CTCs were performed in both grooved-HB chips and wavy-HB 
chips. The results show that similar capture efficiency is obtained in both chips, while the 
wavy-HB chip showed a 39.4% purity, significantly higher than the 25.7% in the 
grooved-HB chip under the same shear rate of 400/s. In the high shear rate range (200/s 
to 400/s), the wavy-HB chip showed up to two-fold higher purity than the grooved-HB 
chip. 
In the following sections, the working principle for the proposed wavy-HB chip is 
first introduced. The capture performance was simulated numerically and compared with 
the grooved-HB chip. Then the fabrication method of wavy-HB chip is described 
followed by its morphology characterization. In vitro tests in both grooved-HB chips and 
wavy-HB chips were investigated and the test results were compared side-by-side in both 
chips. Cell distribution profiles were also studied to help understand the performance 
differences between the grooved-HB chip and the wavy-HB chip. 
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2.2 Method and Materials 
2.2.1 Microfluidic Chip Design, Fabrication and Assembly 
 Both grooved-HB chip and wavy-HB chip consist of a patterned 
polydimethylsiloxane (PDMS) layer at bottom and a PDMS channel layer on top, which 
are aligned and bonded after O2 plasma treatment. The grooved-HB PDMS layer was 
replicated from patterned master, which was fabricated by photolithography method [64]. 
The optimized device layout was sent to CAD/Art Services to make the photomask, 
which was then used to make the patterned master with SU8-2050 (MicroChem, Newton, 
MA). The thickness of the pattern was controlled by the spinning speed of SU8 according 
to the datasheet provided by vendor, which determined both the channel depth and the 
groove depth. The pattern thickness was measured by a profilometer (Alpha-Step D-100 
stylus profiler). To facilitate release of the PDMS mold to the SU8 master, 
1H,1H,2H,2H-Perfluorodecyltrichlorosilane (FDTS) (Alfa Aesar) was coated on master 
by vapor deposition [65].  
A reflow approach, which has been widely used to make micro-lenses [66-67], was 
adopted and modified to make the wavy-HB master, as shown in Figure 2-5(a). In detail, 
a grooved-HB PDMS layer was first fabricated as mentioned above, which was then 
bonded to a glass slide to ensure a relatively stiff PDMS layer. Meanwhile, an SU8 
photoresist layer was spun on a silicon wafer, which was soft baked at 95 °C to remove 
solvent. The grooved-HB PDMS layer was then placed onto the photoresist at 95 °C for 
replication via capillary flow, during which air bubbles were carefully removed by 
pressing the bonded glass. The whole device was cooled down to room temperature (RT) 
and an uncured photoresist grooved-HB pattern was thus replicated by peeling off the 
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PDMS layer. To create smooth wavy pattern, the uncured photoresist pattern was heated 
to 55 °C, where the photoresist could reflow to a certain extent. The heating period was 
well controlled and checked every 10 s by optical microscope till the waves were formed 
(typically 7-10 mins). Devices with different total heating periods were fabricated to 
ensure at least one of the resulted undulations was of the desired dimensions. Finally, the 
wavy-HB SU-8 pattern was UV cured at 365 nm with an intensity of 4.6 mW/cm2, 
followed by a treatment of FDTS. The micropattern topography and morphology was 
examined by a profilometer and an optical microscope. Due to thermal reflow, the final 
pattern depth decreased from 63 μm (grooved-HB) to 45 μm (wavy-HB). To ensure the 
wavy-HB chip has a similar depth of the grooved-HB chip for later cell capture 
comparison, we used the grooved-HB chip with a groove depth of 45 μm. 
2.2.2 Cell Culture and Blood Preparation 
 HCT-116, a colorectal cancer cell line, was used as a model CTC cell line in this 
study. Cultured at 37 °C, HCT-116 cells were incubated with Dulbecco’s Modified 
Eagle’s Medium (Sigma Aldrich) supplemented with 10% fetal bovine serum (Invitrogen) 
and 1% penicillin/streptomycin (Sigma Aldrich). Media was refreshed every 2-3 days. 
When cells reached 80-90% confluency, they were subcultured and 0.05% Trypsin–0.53 
mM EDTA was used for cell detachment. Fresh human whole blood samples with Li 
Heparin as the anti-coagulant agent were purchased from Innovation Research.  
2.2.3 Cell Capture Test and Imaging 
 Before the cell capture test, both the grooved-HB chip and the wavy-HB chip 
were functionalized with anti-EpCAM following a chemistry reaction described in 
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literature, as illustrated in Figure 2-1 [68]. Briefly, 5% (v/v) 3-mercaptopropyl 
trimethoxysilane (MPTS) in ethanol was first injected through the microfluidic chips for 
30 mins. at RT. Chips were then incubated with 0.01 mM N-y-
maleimidobutyryloxysuccinimide ester (GMBS) in ethanol for 30 mins at RT, followed 
by an overnight incubation of 10 µg/mL NeutrAvidin in phosphate buffered saline (PBS) 
at 4 °C. Within 4 hrs of the flow test, the devices were incubated with 10 µg/mL [68-69] 
biotinylated goat anti-human EpCAM in 1% (w/v) bovine serum albumin (BSA) in PBS 
solution for 2 hrs at RT, followed by a purging process with 3% BSA solution containing 
0.05% Tween20 for 30 mins. Between each injection, PBS or ethanol solution was used 
to flush away any unbound molecules in the suspension. To ensure the consistency for 
each device, all the injections were performed using a syringe pump (Harvard Apparatus) 
at a flow rate of 5 mL/hr. 
 HCT-116 cells detached from culture disks were diluted in PBS solution to 103-
Figure 2-1 Illustrative flow chart of surface functionalization on PDMS. 
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105/mL which was calculated by a hemocytometer. To reduce the cell sedimentation in 
the tube during the flow test, 4 mg/mL alginated PBS solution was adopted which mimics 
the blood viscosity [70]. For blood tests, pre-labeled HCT-116 cells with cell-tracker 
(Life Technology) were spiked into blood and fully mixed by gentle pipetting. Cell 
samples of 50-250 µL were then injected into the microfluidic chips using a syringe 
pump in prescribed flow rates. Immediately after the cell injection, PBS buffer solution 
was injected to remove all suspended cells at a flow rate of 3.6 mL/hr with a total volume 
of 1 mL. Captured cells were then fixed using 4% paraformaldehyde for 25 minutes at 
RT and incubated with 0.2% Triton X-100 in PBS for 5 minutes to permeabilize cell 
membranes. Cell nuclei were subsequently stained with DAPI solution for 20 minutes. 
After finishing the staining process the devices were flushed by PBS solution and kept at 
4 °C. To differentiate tumor cells and WBCs, only cells that were cell-tracker positive 
and DAPI positive were treated as HCT-116 cells, while cells which were cell-tracker 
negative and DAPI positive were treated as WBCs. Only cells with intact morphology 
were considered. 
2.2.4 Cell Viability Assay 
 Viability of captured tumor cells was studied by performing LIVE/DEAD assay. 
Specifically, a cocktail including 1 µM calcein-AM and 1 µM ethidium homodimer 
(EthD-1) was flushed through the microfluidic chip. After 25 mins’ incubation at RT, 
PBS solution was added to remove the LIVE/DEAD cocktail. Stained tumor cells were 
then observed under fluorescent microscope. Only cells which are calcein-AM (+) and 
EthD-1 (-) are treated as live, while cells which are EthD-1 (+) are treated as dead. Cell 
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viability was defined as the ratio between the number of live cells and the total number of 
captured cells. 
2.2.5 Finite Element Simulation 
 Customized MatLab codes combined with Comsol simulations were developed 
[71-72] to simulate the cell dynamics in the microfluidic chips. Following previous 
simulation studies [58], cells were treated as particles following streamlines to simplify 
the simulation process. Cell-cell/cell-fluid interactions and the non-Newtonian effects are 
over the scope of this study and not included in this model. In the Comsol model, 
sidewalls were set as the periodic boundaries, which mimic the real setup where there are 
repetitive parallel units. At least 282143 meshes were used to ensure its accuracy and all 
the simulation results were then exported to MatLab for computing the particle motion. 
Cells were treated to be captured when the cell-surface distance was smaller than the 
radius, i.e., 10 μm. 
2.3 Results and Discussions 
2.3.1 Working Principle 
The wavy-HB chip is different from the traditional grooved-HB chip by replacing 
the sharp corners in the latter with smooth wavy structures. The wavy-HB chip consists 
of repetitive units, each of which has six wavy-HB structures in the 1st-half cycle 
staggered with another six wavy-HB structures in the 2nd-half cycle, as depicted in 
Figure 2-2. The design parameters were selected based on prior studies on the mixing 
effect of the grooved-HB chip [73-75]. However, we note that most of prior studies have 
not considered the inherent particulate properties of cells: the main contribution for 
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enhanced cell capture comes from cell-surface direct collisions while the center rotational 
flow might not contribute to the cell capture. To our knowledge, only one pilot study by 
Forbes et al. [58] provides a design guide explicitly based on cell-surface interactions. By 
using the particulate model described in the Methods section, the optimized parameters 
were determined and we found that most optimized parameters are similar to those in the 
previous mixing studies: channel height of 50 μm in the range of 30 μm-110 μm, wave 
amplitude (equivalent to half of groove depth) of 22.5 μm in the range of 6 μm-440 μm, 
short/long arm length of 100 μm/200 μm in the range of 100 μm-800 μm and oblique 
angle between HBs and the flow axis of 45 degrees in the range of 30°-150°. Detailed 
geometrical information is shown in Figure 2-2(c-e). The numerical optimization 
processes for these parameters are not discussed in detail in this study except for the 
wavelength, which differs from other literature work. As shown in Figure 2-3, the pattern 
period was optimized in the range of 40 μm-240 μm, with 160 μm selected in this study 
for the concept validation of the proposed wavy-HB chip. 
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Figure 2-2 Working mechanism of the wavy-HB microfluidic chip for highly efficient 
and selective CTC capture. (a) Schematic figure of a single unit of the wavy-HB pattern. 
(b) Flow velocity components in the cross-section illustrate the micro-vortex. (c) Integral 
of cross flow over the unit for both grooved- and wavy-HB patterns. The contours of the 
shear rate in (d) wavy- and (e) corresponding grooved-HB chips. The color bar is shown 
with the unit of /s. The distortion of the images is due to cut-off of the range in order to 
make the color map clear. The rest area over the range is filled in black. (f) Theoretical 
analysis of cell-surface contact area along one period for both wave and groove patterns. 
For the groove pattern, two data points (2.31 μm2) are not shown when a cell is located in 
the intersection between the bottom and the side wall. (g) The shear rate along the arc 
length of both a groove and wave period (trough-ridge-trough: indicated by the dashed 
line in (d) and (e)) with a distance of a cell radius away from the surface. Here, the arc 
length is normalized to its period for both patterns. 
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With the prototype model built, the working mechanism of the wavy-HB chip is 
explained from capture efficiency and purity. Capture efficiency is defined as the amount 
ratio of captured tumor cells to the total spiked tumor cells. Purity is defined as the 
amount ratio of captured tumor cells to the total captured cells including tumor cells and 
non-specifically captured WBCs [34-35].  
To achieve high cell capture efficiency, we used HB structures here to take 
advantage of the chaotic effect and micro-vortices as illustrated in Figure 2-2(b). To 
quantify the mixing effect, the integrals of cross-flow in one unit for both grooved-HB 
chips and wavy-HB chips were calculated following: 
  2 2If v w dV                               (2-1) 
where v and w are velocity components in y and z directions, respectively. The 
comparison results showed that the wavy-HB chip has nearly the same flow mixing 
performance as that of the grooved-HB chip (see Figure 2-2(c)). In addition to the mixing 
effect, pattern surface area and cell-surface contact area were considered to predict cell 
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Figure 2-3 Numerical simulation reveals the effect of the groove period on capture 
efficiency. 
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capture efficiency. Here, cell-surface contact area was calculated for the fractional cell 
membrane with a separation distance of a ligand-receptor bond length, i.e. 20 nm [72], 
from the substrate. On substrates of different surface curvatures, cells have different cell-
surface contact modes. As sketched in Figure 2-4(a-b), on a grooved-HB pattern, a cell 
contacts the flat region of the patterned surface vertically, while on a wavy-HB pattern, 
the cell contacts the surface either on the concave trough or the convex peak. Although 
Figure 2-4(c) shows that the total pattern surface area of the wavy-HB pattern is slightly 
less than that of the grooved-HB pattern (6.34x10-8 μm2 vs. 8.98x10-8 μm2), the 
effective cell-surface contact area for the wavy-HB pattern outweighs that for the 
grooved-HB pattern along the majority surface of one period, as shown in Figure 2-2(f). 
Both theoretical and numerical investigations suggest a comparable cell capture 
performance for the wavy-HB chip compared to the grooved-HB chip. 
 
To achieve high cell capture purity, we integrated smooth wavy structures into the 
wavy-HB chip, as illustrated in Figure 2-2(a, d). The smooth corners in the wavy-HB 
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Figure 2-4 Illustrations of cell-surface contact modes on (a) wavy pattern and (b) 
grooved pattern. Plot is not in scale. (c) Total pattern surface area for one period of 
groove and wave patterns calculated based on prescribed geometries. 
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chip eliminate regions with ultra-low shear rate presented in the grooved-HB chip, which 
tend to trap WBCs non-specifically. The shear rate at the wall was derived as follows, 
 
6
2
Q
H W
                           (2-2) 
where Q is the flow rate, H and W are the height and width of the channel, respectively. 
The shear rate at a specific location was calculated from the spatial derivation of the local 
velocity as follow, 
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where u, v and w are the component velocities in the x, y and z direction, respectively. As 
indicated in Figure 2-2(g), under the same inlet flow condition with a shear rate of 60/s, 
the minimum shear rate in the wavy-HB chip (6.41 /s) is almost 15-fold higher than that 
in the grooved-HB chip (0.44 /s). It was also noticed that the ultra-low shear rate happens 
in both bottom left and right corners in the grooved-HB chip. As a result, the wavy-HB 
chip is expected to have a better performance in purity when compared with the grooved-
HB chip. 
2.3.2 Wavy-HB Chip Design, Fabrication and Assembly 
 Figure 2-5(a) shows the reflow fabrication process for making a wavy-HB silicon 
master. The reproducibility of the fabrication method were validated by measuring the 
wavy profiles in three fabricated samples. Figure 2-6 indicates that the reflow method is 
consistent in generating wavy patterns, although further improvement is still needed. The 
undulation features of the wavy-HB structures were qualitatively observed using optical 
microscopy in Figure 2-5(b), with detailed dimensions measured in Figure 2-5(c). To 
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further characterize the wavy structures, a replicated PDMS wavy-HB layer was cut 
along the wave propagation direction and observed under the microscope. Figure 2-5(d) 
clearly shows that wavy structures were obtained from the reflow process with a 
wavelength of 160±2 μm and an amplitude of 22.5±1.5 μm (see Figure 2-5(e)). Figure 
2-5(f) shows a typical assembled wavy-HB chip under flow tests. To perform comparison 
flow tests, geometry equivalent grooved-HB chips were fabricated and assembled 
following the traditional photolithography method (Images not shown). 
 
Figure 2-5 Illustration of the wavy-HB chip and its fabrication process. (a) 
Fabrication process of the wavy-HB master. The "level down" and "level up" are due 
to the photoresist melting. Micrograph images of (b) top view for the silicon molds 
(Scale bar, 200 μm) and (d) side view for the assembled chip (Scale bar, 50 μm) 
illustrate the detail periodic designs and the wavy structures. The assembled chip was 
cut along the dashed line marked in (b) to obtain the side view. (c) and (e) sketch the 
layout of the wavy-HB structures with the detailed parameters. The red spheres stand 
for cells flowing in the channel. (f) Sample injection into a wavy-HB microfluidic 
device consisting of one inlet and one outlet. (Scale bar, 10 mm)  
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2.3.3 Wavy-HB Performance Validation by Cell Capture Tests 
 To evaluate the device performance, the distributions of both CTCs and WBCs 
along the flow direction were investigated first. Shear rate ranging from 60/s to 400/s, 
which were commonly used in literature [35, 76], was studied here. Captured CTCs and 
non-specifically bound WBCs in the first 20 sections of each window with a width of 
1.14 mm were counted and normalized in percentage, as shown in Figure 2-7(a)-(d). It is 
found that focusing regions of CTCs tend to move towards the tail sections with 
increasing shear rate in both grooved-HB and wavy-HB chips (Figure 2-7(a)-(b)). This 
shift is speculated due to the increased shear force proportional to the increasing shear 
rate, which agrees well with the results in literature [59]. Interestingly, the wavy-HB chip 
presents a relatively more uniform distribution with the focusing sections shifted more 
towards the tail section when compared with the grooved-HB chip. It can be explained by 
the fact that the smooth wavy patterns lack extremely low shear-rate sections (namely, 
the sharp trough sections in the grooved-HB chip), allowing for more cells to flow 
Figure 2-6  Profilometer results of the wavy pattern for three samples made by the 
reflow approach. 
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towards the tail section, which is especially reflected at lower shear rates (60/s and 100/s). 
WBCs also exhibit a similar trend with the focusing sections shifting towards the tail 
sections with the increasing shear rate (Figure 2-7(c)-(d)), although the trend is not so 
significant compared with that for CTCs. This is attributed to the inherent weak non-
specific capture force for WBCs, which allows WBCs to have a relatively longer flow 
pathway. It is also noticed that there are small percentages of peaks in the entry section 
under lower shear rates (60/s and 100/s), which are probably due to the geometry 
transition from the flat plane to the patterned regions, namely, wavy or grooved structures.  
 
Figure 2-7 Distributions of CTCs along flow direction in (a) grooved patterns and (b) 
wavy patterns; Distribution of WBCs along flow direction in (c) grooved patterns and 
(d) wavy patterns. The microfluidic device is equally divided into parallel sections 
along the flow direction, with the first 20 sections with a width of 1.14 mm shown here. 
Curve fitting are adopted in each group to indicate the trend of the cell distribution 
profile. 
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To demonstrate the performance of the proposed wavy-HB chip, cell tests in both 
PBS buffer solution and whole blood were performed. To differentiate tumor cells and 
WBCs, fluorescent images were recorded through the whole chip. As illustrated in Figure 
2-8(a)-(c), only cells of celltracker (+) and DAPI (+) were treated as tumor cells, while 
cells of celltracker (-) and DAPI(+) were treated as WBCs. The overall trend of capture 
efficiency and purity under different shear rates agrees well with literature results [59]: 
Figure 2-8(d) shows that capture efficiency decreases with increased shear rate in all 
cases due to the decreased duration for cell-surface interactions and the increased shear 
detachment force; Figure 2-8(e) shows that purity increases with increasing shear rate 
mainly due to the increased shear detachment force to flush away more WBCs (non-
specific, weak bonds) than tumor cells (specific, strong bonds). In comparison to the 
grooved-HB chip, the wavy-HB chip has a similar cell capture performance with a 
difference smaller than 10.0% in most test conditions, which was already indicated by the 
similar mixing effects in Figure 2-2(c). On the other hand, the wavy-HB chip performs 
significantly better than the grooved-HB chip in purity especially in the high shear rates 
of 200 /s and 400 /s: enhancements of 43.4% (36.7%±2.2% vs. 25.6%±1.7%) and 53.3% 
(39.4%±4.3% vs. 25.7%±2.1%) are achieved, respectively. In another word, much less 
WBCs were non-specifically captured in the wavy-HB chip. Under the highest capture 
efficiency condition (i.e. 60/s) where 1 mL blood test was performed, around 2500 WBCs 
were captured on the wavy-HB chip in comparison to 4500 WBCs on the grooved-HB 
chip. These results also agree with the previous finding that HB pattern overweighs the 
micropost-based CTC-Chip (around 5000 WBCs) in terms of the purity [34-35]. By 
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introducing asymmetrical structures, Sheng et al. [55] improved the purity but the amount 
of non-specific WBC was still around 3500. 
 
Notably, higher tumor cell capture efficiency was achieved in blood cases compared to 
PBS cases in both wavy-HB chips and flat devices, as shown in Figure 2-8(d). Taking the 
shear rate of 60/s as an example, an enhancement of 8.83% was obtained in the wavy-HB 
chip (85.0%±6.8% vs. 78.1%±10.1%). Furthermore, an enhancement up to 67.4% was 
obtained in the control flat channel (32.8%±5.8% vs. 19.6%±0.9%). We hypothesize that 
Figure 2-8 Tumor cells capture in the wavy-HB and grooved-HB chips (a)-(c) Cell-
tracker and DAPI fluorescent differentiation of tumor cells and WBCs. Both tumor 
cells and WBCs are DAPI positive in (a), while only pre-labeled CTCs are cell-
tracker positive in (b). The merged image in (c) shows only cells which are DAPI (+) 
and cell-tracker (+) are regarded as tumor cells, while cells which are DAPI (+) and 
cell-tracker (-) are regarded as WBCs. (Scale bar, 80 μm) (d) Capture efficiency vs. 
shear rate in the grooved-HB chip, the wavy-HB chip, and the flat device. (e) Purity 
vs. shear rate in both chips. Error bars stand for standard deviations in three 
independent experimental trials. 
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the enhancement comes from the margination effect of tumor cells towards the channel 
surface. It has been suggested that more deformable red blood cells would migrate 
towards the channel center while the stiffer tumor cells are repelled towards the channel 
surface [77]. By comparing the enhancement level for the wavy-HB chip and the flat 
device, it was also suggested that the margination effect induced by blood contributes 
more in the flat channel. The margination effect in the wavy-HB chip might be disturbed 
and thus reduced by the micro-vortexes. Interestingly, although similar enhancement 
attributed to blood was not observed in the grooved-HB chip at 60/s (92.1%±4.6% vs. 
95.0%±12.4%), an enhancement up to 123.5% was obtained at high shear rates, i.e., 
200/s and 400/s. This suggests that the existence of normal cells contributes more to 
efficient tumor cell capture at high shear rate, although the mechanism is not clear yet. 
The viability of tumor cells under different shear rates was also studied by 
performing the LIVE/DEAD assay in both grooved-HB and wavy-HB chips, using the 
flat channel as a control. Figure 2-9(a)-(d) show typical micrographs of LIVE/DEAD 
assay results under 60/s and 400/s for both chips. Cell viability was then calculated by 
counting the amount of live cells and dead cells in these fluorescent images. As 
illustrated in Figure 2-9 (f), the viability decreases with increased shear rate, indicating 
that captured tumor cells are prone to lose their function under high shear rate. The 
comparison reveals that the wavy-HB chip offers a higher cell viability than the grooved-
HB chip, suggesting that the captured tumor cells are more physically intact in the wavy-
HB chips. Especially under the high shear rate of 400/s, the cell viability enhancement in 
the wavy-HB chip is more significant over the grooved-HB chip with an 11% 
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improvement (89.29%±4.91% vs. 80.65%±2.64%). It is speculated that more cell deaths 
are attributed to damages induced by sharp corners in the grooved-HB chip. 
 
In addition, the clinical utility of the wavy-HB chip was also validated by the 
isolation of tumor cells in PBS buffer solution at concentrations of 10, 100, 500 and 1000 
cells/mL. The test shear rate was 60/s for all cases, where capture efficiencies of around 
80% were achieved, as shown in Figure 2-10. The linear regression study results show 
that the device has a consistent performance under the test conditions with different 
spiked tumor cell amounts. This suggests that the wavy-HB chip has the potential to 
fulfill the clinical requirement to detect very rare CTCs, i.e., 1-10 cells/mL blood. 
Figure 2-9 Viability of captured tumor cells in the wavy-HB and grooved-HB chips. 
Representative fluorescent micrographs of the captured tumor cells in the grooved-HB 
chip after LIVE/DEAD a under the shear rate of (a) 60/s and (b) 400/s. LIVE/DEAD 
stain results in the wavy-HB chip under the shear rate of (c) 60/s and (d) 400/s, 
respectively. (e) LIVE/DEAD stain results in the flat channel under the shear rate of 
60/s. Cells which are calcein-AM (+) and EthD1 (+) are treated as dead, as indicated by 
white arrows in (a)-(e). (f) Quantitative analysis of viability of captured tumor cells in 
the wavy-HB and grooved-HB chips under different shear rates. Error bars stand for 
standard deviations in three independent experimental trials. (Scale bar, 160 μm)  
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2.3.4 Cell Distribution along One Pattern Period and Its Indication for 
Device Performance 
Distribution of tumor cells and WBCs along a single pattern period was then 
studied. Representative fluorescent optical micrographs of tumor cell distributions in the 
grooved-HB chip and wavy-HB chip are shown in Figure 2-11(a) and (b), respectively. A 
period is defined as the region between two consecutive troughs which is equally 
distributed into 20 sections following the flow direction, as illustrated in Figure 2-11(c)-
(f). For tumor cell distributions under increased shear rate, grooved-HB patterns have a 
focusing region in the trough close to the upstream groove sidewall, with the section 
shifting more towards the groove side wall. On the other hand, wavy-HB patterns have a 
relatively focusing region shifting from the lower upstream slope to higher upstream 
slope, as shown in Figure 2-11(c)-(d). For WBC distributions under increasing shear rate, 
grooved-HB patterns have focusing regions in both upstream and downstream trough 
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Figure 2-10 Linear regression analysis of the captured cell amount versus spiked cell 
amount. HCT-116 cells at various concentrations were spiked in PBS buffer solution 
and captured cell amount were then counted. Error bars stand for standard deviations in 
three independent experimental trials. 
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regions with the section shifting more towards the downstream trough section, while 
wavy-HB patterns have focusing sections shifting from trough sections to the regions 
close to the peak, as shown in Figure 2-11(e)-(f). Notably, the WBC distributions under 
increasing shear rate exhibit a dramatic difference in these two chips: WBCs tend to be 
trapped in the trough sections close to the downstream side wall for the grooved-HB chip, 
especially under larger shear rates (200/s and 400/s) as shown in Figure 2-11(e), while for 
the wavy-HB chip, WBCs shift from the trough to the regions close to the peak where 
shear detachment force is large and WBCs detachment is easy to happen as shown in 
Figure 2-11(f). This trend difference is probably attributed to the geometry difference: the 
sharp grooved structure resists WBCs from rolling upwards to the ridge while the smooth 
wavy structure allows WBCs to roll towards to the peak region. Following this reasoning, 
under larger shear rates, more WBCs in the wavy-HB chip are prone to be pushed from 
the trough to the peak, where the shear detachment force is relatively larger as shown in 
Figure 2-2(d). As a result, the wavy-HB chip is subjective to a high purity under larger 
shear rate, which agrees with the experimental data in Figure 2-8(e).  
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2.4 Discussion 
 The distribution profiles of tumor cells and WBCs shown in Figure 2-11 are 
explained by a two-regime based mechanism, i.e. adhesion-detachment force balance and 
cell-surface contact frequency. In other words, the peak capture regions are always where 
there are more cell-surface contacts with the pre-requisite of the adhesion force large 
enough to resist the shear detachment force. In the grooved-HB patterns, two factors 
contribute to the cell distribution: (1) large cell-surface contact frequency exists in both 
groove sides and the ridges, as shown in Figure 2-12(c); (2) cells experience larger shear 
Figure 2-11 Illustrative micrograph images of tumor cells distributions in (a) a grooved-
HB chip and (b) a wavy-HB chip. (Scale bar, 80 μm) Quantitative distributions of tumor 
cells along one pattern period in (c) the grooved-HB chip and (d) the wavy-HB chip. 
Distribution of WBCs along one pattern period in (e) the grooved-HB chip and (f) the 
wavy-HB chip. One pattern period is defined as trough-peak-trough indicated as the 
dotted line in (a) and (b). A pattern period is equally divided into 20 sections along the 
flow direction with a width of 8 μm. Schematic images of the divided patterns are also 
shown in (c)-(f). Curve fits are used to indicate the cell distribution patterns. 
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detachment forces in the ridges and smaller ones in the troughs, as indicated in Figure 
2-2(d)-(e) and Figure 2-2(g). As a result, both tumor cells and WBCs tend to be collected 
in the trough sections close to the groove sides, as indicated in Figure 2-11(c) and Figure 
2-11(e). Moreover, with increasing shear rate, tumor cells tend to be focused close to the 
upstream sidewalls while WBCs are close to the downstream sidewalls, which is 
reasoned due to the difference in adhesion force. The weaker non-specific adhesion force 
for WBCs yields a shift of focusing regions towards the smaller shear rate sites, namely, 
the troughs close to the downstream sidewalls. Similarly, in the wavy patterns, with 
relatively strong adhesion forces due to the larger cell-surface contact areas, tumor cells 
tend to be collected in the higher upstream sections, which have higher cell-surface 
contact frequency (Figure 2-12(c)). With the increasing shear rate, the slight shift towards 
the higher downstream sections is due to the increasing detachment force that makes cell 
distribution more uniform. On the other hand, WBCs are speculated to readily shift along 
the wave due to weak adhesion forces. At lower shear rates (60/s and 100/s), WBCs are 
easily removed in the regions with higher shear rate, i.e. ridge, thus they tend to be 
collected at the troughs where the shear rate is low (see Figure 2-2(d)). With shear rate 
continuously increasing to higher values (200/s and 400/s), non-specifically captured 
WBCs are pushed back and forth along the wave and their distributions shift as indicated 
in Figure 2-11(f). The detail non-specific adhesion mechanism for WBCs on anti-
EpCAM coated surface is not clear so far. 
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The tumor cell capture experimental results are in good agreement with the 
computational prediction. On one hand, the overall tumor cell capture efficiency is well 
predicted by the integral of cross flow, which indicates similar mixing effects between 
grooved-HB and wavy-HB chips. The slight difference of capture efficiency might be 
attributed to the decreased surface area during the reflow process, where the surface areas 
of a single pattern period for the grooved-HB and wavy-HB pattern are 8.98×10-8 m2 and 
6.34×10-8 m2, respectively (see Figure 2-4(c)). It should be noted that local distribution 
does not necessarily offer the overall picture of the tumor cell capture efficiency. As 
shown in Figure 2-7, although a larger portion of tumor cells are trapped in the head 
sections of the grooved-HB chip, the distribution decreases very fast along the flow 
direction. On the contrary, the wavy-HB chip shows a relatively uniform distribution 
along the whole flow direction. To evaluate cell capture efficiency, accumulation of 
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Figure 2-12 Numerical simulation reveals cell-surface contact frequency in the 
grooved-HB chip and the wavy-HB chip. The locations for cell-surface interactions, 
including the pattern ridge (green), channel top (red), pattern bottom (black) and 
pattern side (blue) in (a) the grooved-HB chip and (b) the wavy-HB chip. The upstream 
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captured cell across the whole chip should be considered. On the other hand, the 
computational results are used to explain the local distribution of tumor cells. For 
example, compared to the wavy-HB chip, the trough section for the grooved-HB chip has 
lower shear rate (see Figure 2-2(d-e)) but shows similar cell surface contact frequency 
(see Figure 2-12(c)). As a result, a larger proportion of captured tumor cells are present in 
the trough section for the grooved-HB chip in comparison with the wavy-HB chip as 
shown in Figure 2-11(c-d). Meanwhile, the lower shear rate in the trough region also 
brought more WBCs to be non-specifically captured, which was confirmed by the WBC 
local distributions as shown in Figure 2-11(e-f). 
In literature, there have been a few attempts to develop tumor cell isolation chips 
derivative from the grooved-HB patterns [59, 78-79], but all with sharp corners. Our 
theoretical and computational analyses reveal the fundamental limitation of the sharp 
grooved patterns, i.e., ultra-low shear rate regions close to the groove corners (see Figure 
2-2(g)) thus increasing the chance of non-specific cell capturing. By introducing the 
smooth wavy-HB structures in the current configuration, ultra-low shear rate regions are 
eliminated as shown in Figure 2-2(g). Our results have demonstrated an enhanced purity 
by 43.4% compared to that from the grooved-HB structures, which is crucial for down-
stream analysis like high quality cell profiling and thorough genomic analysis [80-81]. 
For example, it is an essential need to achieve high purity for DNA microarray analysis 
[82]. Enhanced purity obtained in our wavy-HB chip can reduce the influence introduced 
by impure WBCs, leading to a more reliable gene data analysis. Further enhancement can 
be achieved by introducing asymmetry between the trough and ridge sections of the wave, 
as WBCs are easily trapped in the trough as shown in Figure 2-11(e-f), which is also 
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suggested by other work [55]. More importantly, the proposed idea to smooth sharp 
grooves can be adopted as a general strategy in other existing devices to improve the 
purity while preserve capture efficiency.  
Challenges still exist on the anti-EpCAM based approach for CTC isolation. First, 
CTCs present heterogeneous phenotypes for different cancer types [83] and EpCAM 
expression levels could also be down-regulated over the course of metastasis and 
dissemination [84]. Thus, the capture yield may drop for CTC subpopulations of non-
epithelial and EpCAM down-regulated phenotypes. A potential strategy to tackle this 
challenge is to vary the antibody type in the wavy-HB chip [85]. It was also demonstrated 
that higher antibody coating density can enhance CTC isolation34, which can reduce the 
loss of EpCAM down-regulated CTCs. Another challenge for the current approach lies in 
how to effectively release captured CTCs. Xu et al. [86] tried to directly detach the 
captured CTCs by flushing air while the release efficiency was only 45% partially due to 
the dead volume in the sharp groove. This can be significantly improved in our smooth 
wavy pattern by eliminating the sharp groove regions where cells are readily trapped. To 
further overcome this problem, we can replace anti-EpCAM by other environment 
stimulated substances, like aptamers [87] and polymer materials [88]. We believe the 
combined high efficiency and high purity in our wavy-HB chip together with the 
modified surface coating will allow for further enhancement of CTC capture and post-
analysis for various applications. 
2.5 Conclusion 
 In summary, a wavy-HB chip coated with anti-EpCAM has been demonstrated 
with high efficiency and purity in isolation of tumor cells from the spiked whole blood. 
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Due to the staggered HB structures adopted from the hallmark grooved-HB chip, high 
capture efficiency up to 85.0% is achieved by the induced passive mixing. In comparison 
with the grooved-HB chip with sharp corners, the wavy-HB chip has the smooth wavy 
patterns, leading to nearly two-fold enhanced cell capture purity up to 39.4%. The 
enhancement is mainly due to the lack of the ultra-low shear rate regions in the grooved-
HB chip. In addition, the wavy-HB chip serves as a better tumor cell isolation platform in 
that its inherent gentle nature induced by the smooth undulations (maximum shear rate is 
645.9 /s compared to 1084.1 /s in the grooved-HB chip in the shear rate of 400 /s) 
protects cells from deformation forces and keeps cells intact. Despite the promising 
results achieved in the wavy-HB chip, it is noticed that the trade-off between capture 
efficiency and purity still exists. It has been suggested that integration of nanostructures 
could potentially address this issue [54, 89-90], which will be implemented into our 
wavy-HB chip in the future. Further, patient blood samples will be tested on the wavy-
HB chip to validate its clinical utility. 
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Chapter 3: Geometry Optimization 
for Grooved-HB Chip 
 
3.1 Introduction 
 Using of microfluidic chips for capturing circulating tumor cells (CTCs) has 
raised lots of interests recently and various microfluidic platforms have been developed 
with demonstrated clinical utilities [91-94]. One main criteria to evaluate the device 
performance is to achieve high CTC capture efficiency, which is defined as the ratio of 
amount of captured CTCs and the total number of CTCs. Among those methods 
developed in literature, immnuoaffinity based approach has been widely adopted to 
achieve this goal. This is attributed to the fact that most CTCs are cells of epithelial 
origin and uniquely over-expressed epithelial cell adhesion molecules (EpCAM), which 
other normal cells do not express. Due to the laminar nature of flow in a typical 
microfluidic device, interactions between cells and the microfluidic wall are not readily 
accessible which is essential for cell capture. Therefore, the main challenge for achieving 
the goal of high CTC capture efficiency lies in how to effectively bring CTCs close 
enough to anti-EpCAM coated surfaces to form ligand-receptor capture bonds.  
 In recent years, integrations of various complex geometry patterns into 
microfluidic chips have been proposed to increase CTC interactions with anti-EpCAM 
coated surfaces. Nagrath et al. [34] reported a microfluidic chip with an array of 
microposts, which precisely controls the flow path to enhance the CTC-pillar interactions. 
The inherent laminar flow property limits its capture efficiency to 65% in the flow rate of 
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1.1 ml/hr. To overcome this limitation, approaches to disturb the laminar pattern attracts 
lots of attention from researchers. Stroock et al. [56] firstly reported a staggered 
herringbone structure to generate passive chaotic mixing. Integration of this structure into 
microfluidic chips was then widely adopted for CTC capture with significantly increased 
capture efficiency [35, 78, 87]. The NanoVelcro CTC chip developed in Tseng's group 
[59, 95] consisted of both herringbone PDMS structures and nanopillars, which achieved 
a capture efficiency up to 95%. By tuning the pillar size and spacing, maximized CTC 
capture occurred when the pillars had an estimated diameter of  120 nm and spacing of 
140-200 nm [68]. 
 The key mixing mechanism in the herringbone structure lies in the transverse flow 
patterns which stretch and fold the fluid volumes, thus allowing a short distance for fully 
mixing. Numerous studies have also been performed to quantitatively investigate the 
herringbone geometry effect on the flow mixing. Stroock et al. [56] evaluated the mixing 
performance of different HB devices by measuring the mixing length from confocal 
microscopy imaging. However, its complexity in device fabrication and repetitive flow 
tests limits its applications to a certain extent. Instead, owing to its inherent easy access, 
computational fluid dynamics (CFD) methods have been extensively applied on studies 
of geometric optimization studies. Various characterization methods have been adopted 
to evaluate the mixing effect including maximum striation thickness measurement [73, 96] 
residence time analyses [97-98] and Poincare maps analysis [99]. A general criterion for 
the optimized mixing effect of a HB device has been concluded by Lynn [74]. That is: (1) 
the HB structure has an optimized width fraction of the short arm of 1/3 and an optimized 
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oblique angle of 45°; (2) The mixing effect strongly relies on the groove depth ratio while 
weakly depends on the channel aspect ratio. 
 However, although the herringbone structure is widely used to enhance the flow 
mixing, concerns regarding these adopted geometry guides for enhancing CTC capture 
still hold, in that enhanced internal flow mixing does not necessarily lead to an increase 
of CTC-surface interactions. Flow mixing happens in the whole cross-section indicating 
the strength of the inter-diffusion, thus it does not fully correlate to the ability to push 
CTCs towards the anti-EpCAM coated surface. From this perspective, a model to 
consider the cell-surface interactions is needed. Forbes et al. [58] pioneered the study to 
research on the particle-surface interactions in a herringbone micromixer. When it comes 
to the specific field of CTC capture study, the limitation lies in the fact that it does not 
directly correlate to the capture efficiency with geometry parameters, nor does it consider 
the cell adhesion probability which exists in CTC capture studies [76, 100-101]. As such, 
a more comprehensive model considering the adhesion probability is in need for 
optimizing the herringbone geometries for enhanced CTC capture. 
 In what follows, the computational model with adhesion probability is firstly 
introduced. Then the model is validated through an experimental comparison in terms of 
both capture efficiency and cell capture distribution. A systematic study is lastly pursued 
to investigate the geometrical effects of various parameters of herringbone structures on 
CTC capture. The conclusion obtained from this work can provide as a geometry guide 
for researchers to optimize and design their devices accordingly, rather than running 
repetitive experimental tests in devices with a huge matrix of different geometries. 
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3.2 Numerical Methods 
 In this study, we developed an in-house code integrated with finite element 
method (FEM) based flow simulation to study the cell transport and capture dynamics. 
This numerical approach was carried out in three steps. First, FEM simulations of the 
flow domain were performed to obtain flow velocities, pressure and other derivatives 
using the fluid dynamics module in COMSOL, a widely used software in computational 
fluid dynamics (CFD) [71, 102-103]. Then cells were simulated to transport in the flow 
domain following the governing equation. Under prescribed criterions regarding cell-
surface interactions, flowing cells were determined to be captured or not.  
3.2.1 Flow domain simulation 
 For a microdevice of herringbone structures, the geometry was designed 
following the outline proposed by Stroock et al. [56], where repetitive herringbone 
grooves were staggered to induce chaotic effects. To simplify the simulation, only one 
unit of herringbone grooves was considered, as shown in Figure 3-1. The unit consists of 
a flow channel and two half cycles of herringbone grooves. In this study, various 
parameters were investigated including the number of grooves for one half cycle (n), 
intersection angle between two grooves (θ), channel height (h), groove depth (d), channel 
width (w), the percentage (p) of a groove width (wg) out of a groove pith (wp), 
asymmetric factor (β) defined as the fraction of the narrow arm in a channel width. After 
the model was built with the prescribed geometrical parameters, tetrahedral elements 
were applied for meshing the model with a minimum element quality of 0.047. A grid 
convergence study was performed to investigate the mesh quality. Mesh refinements 
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ended until difference smaller than 2% was achieved for both flow velocities and 
pressures between two simulations.  
 In the fluid domain, alginated phosphate buffered saline (PBS) solution with a 
density of 1.007x103 kg/m3 and a viscosity of 3.3 x10-3 Pa·s was used as the medium [70]. 
The boundary conditions were set as follows: a parabolic flow profile was assigned to the 
inlet where it was assumed that the flow field was fully developed; a gauge pressure of 0 
was assigned to the outlet; side walls were set as periodic boundary which mimics the 
real application where there are many parallel units; all other surfaces were set as wall 
where the velocity was equal to 0. The flow domain was then simulated by solving the 
incompressible Navier-Stokes equation below: 
𝜌?⃗? ∙ ∇?⃗? = −∇𝑃 + µ∇2?⃗?               (3-1) 
where U is the flow velocity, P is the pressure, 𝜌 and µ are the density and viscosity of 
fluid medium, respectively. 
3.2.2 Cell Transport Dynamics  
In-house developed codes were used to simulate the cell transport in a microfluidic 
device. To simplify the simulation, cells were treated as dots with a virtual radius of 10 
μm and a density of 1.06×103 kg/m3. Fluid-cell interaction and cell-cell interaction were 
neglected in this model. These simplifications were also adopted in other studies in 
literature [58]. More comprehensive studies taking these factors into account could be 
found elsewhere [104-105], while it was too computationally expensive and time 
consuming for a geometrical study. 
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To simulate cell transport dynamics, a dose of cell-mimicked particles with a 
constant supply of 1000 particles per 0.1 s were periodically injected through the inlet, 
which mimics a continuous cell injection. The flowing cells transported in the 
microfluidic chip following the governing equation as shown below, 
 
adv sed diff shearm    v F F F F                   (3-2) 
where m  and v  are the mass and velocity of a single cell, respectively. advF , sedF , diffF  
and shearF  are the force induced by advection flow, cell sedimentation resulted from cell 
weight and fluid floating, Brownian Motion induced diffusion and shear induced 
migration, respectively. Here, a time-scale analysis was performed to evaluate the 
dominance of each force [58]. Given the geometry used in Stroock's work [56], the time 
scale induced by diffusion was 
2
h
diff
D
t
D
   which equals to 1.51×106 s; the one by shear 
induced migration was 
2
2
h
shear
p
D
t
R D
  which equals to 1.96×108 s; the one by 
sedimentation was 2
9
2
h
sed
p
D
t
gR


   which equals to 28.3s; the one by advection was 
h
adv
D
t
U
   which equals to 0.08s, where 4h
AD
P
  (A is the channel cross-section area 
and P the perimeter), D is the diffusivity of the particle. It was noticed that difft  and sheart  
were several orders of magnitude larger than advt  and sedt . In other words, the cell 
transport in the microfluidic chip was dominated by advection force and sedimentation 
force, while the Brownian motion induced diffusion force and the shear induced 
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migration force were neglected. Thus, the governing equation was simplified to the 
format described as follows: 
 adv sedm  v F F                    (3-3)  
3.2.3 Cell Capture and Adhesion Probability Integration 
 Flowing cells were treated to contact with the capture bed when the cell-surface 
distance was smaller than the radius of a cell, i.e., 10 μm. With the fact that the cell-
surface interaction is a dynamic process which involves the continuous 
breakage/formation of ligand-receptor bonds, adhesion probability was introduced to 
reflect this overall performance and determine whether a cell was firmly captured, which 
was formulated as below [62]: 
 dislodgeexpor l a c
B r c
F
P m m K A
K T m A
 
  
 
         (3-4) 
where rm  and lm are the receptor density and ligand density, respectively, 
o
aK  is the 
receptor–ligand association constant at zero load, cA  the contact area, λ the bond length,
BK T  the thermal energy and dislodgeF  the dislodging force. Several studies in literature 
have also adopted the adhesion probability to study the CTC capture in various 
microfluidic devices [100, 106]. However, for a specific biological problem like CTC 
capture in this study, hurdles usually existed due to the lack of information about rm , lm , 
o
aK  and λ. A few attempts have been made to overcome this problem. Notably, Smith 
[100] firstly introduced two lumped parameters A and B to simplify the formula into the 
format as shown below: 
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  expP A B             (3-5) 
 
where or l a cA m m K A  and 
B r c
k
B
K T m A

  . Meanwhile, it was assumed that the 
dislodging force was proportional to the shear stress. With this simplified lumped model, 
the unknown reduced to only A and B, compared to five parameters in eqn. (3-4). 
 In equation (2), A described the probability when the shear rate was zero and B 
denotes the trend of adhesion probability under different shear stress. By taking 
advantage of these properties, we calculated A and B based on two experiments. To 
determine B, a Hele-Shaw design was created where the shear stress linearly decrease in 
the flow direction [107]. Cell capture test was then performed to study the cell 
distribution along the flow direction. Here, a high concentration of 106/mL was applied 
so that the assumption held that a constant concentration was over through the whole 
device. As a result, the adhesion probability was directly proportional to the amount of 
captured cells at each shear stress. A curve fit of the adhesion probability vs. shear stress 
was then performed to obtain B. To determine A, a cell capture test was performed in a 
herringbone microfluidic device under a prescribed shear rate. By iterating A, a best 
match could be found between the experimental result and the computational result. Thus, 
the integrated model with adhesion probability was established and ready for following 
geometrical studies. 
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3.3 Experiments 
3.3.1 Microfluidic Chip Design and Fabrication 
 To experimentally obtain A and B, both Hele-Shaw design and herringbone design 
were drafted by AutoCAD software. Specifically, the Hele-Shaw design had an inlet 
width of 5 mm and channel height of 100 μm, while the geometry profile of two side 
walls were defined to achieve a linearly decreased shear stress along the flow direction: 
125
50
y
x


 (mm) . The herringbone structure was designed to follow the geometry in 
Stroock's work [35]. These designs were then sent out to CAD Inc. for photomasks. 
Standard photolithography method was used to fabricate the SU8 master mold, followed 
by a silane treatment to make the surface hydrophobic which allows for an easy peeling 
of PDMS. 
3.3.2 Surface Functionalization 
 To capture rare tumor cells, antibodies against epithelial adhesion molecules 
(anti-EpCAMs) were coated on the channel surface which allow for bond formations 
uniquely with tumor cells. This was achieved following a standard surface 
functionalization process [35]. Briefly, PDMS slabs were plasma treated and assembled 
into a microfluidic device, immediately followed by an incubation of 5% (v/v) 3-
mercaptopropyl trimethoxysilane (MPTS) in ethanol for 30 min. at room temperature 
(RT). The device was then incubated with 0.01 mM N-y-
maleimidobutyryloxysuccinimide ester (GMBS) in ethanol for 30 mins and another 
overnight incubation of 10 µg/mL NeutrAvidin in PBS at 4 °C. Before the test, 
biotinylated goat anti-human EpCAM in 1% (w/v) bovine serum albumin (BSA) in PBS 
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solution was added to the device and incubated for 2 hrs at RT, followed by an incubation 
of 3% BSA solution containing 0.05% Tween20 for 30 min to reduce non-specific cell 
capture. PBS or ethanol solution was used to remove the excessive solution from the 
previous injection. To make each functionalization consistent, a syringe pump (Harvard 
Apparatus) was used for each injection at a flow rate of 3.5 mL/hr. 
3.3.3 Cell Culture 
 HCT-116 cells was used as a model cancer cell line in this study as colorectal 
cancer is among the most common cancers [108]. Cell culture medium comprised of 
Dulbecco’s Modified Eagle’s Medium (Sigma Aldrich), 10% fetal bovine serum 
(Invitrogen) and 1% penicillin/streptomycin (Sigma Aldrich) was renewed every 2-3 days. 
0.05% Trypsin–0.53 mM EDTA was used to detach cells upon 80-90% confluency. 
3.3.4 Cell Capture Test 
 Before cell capture test, detached cells were counted by hemocytometer and 
diluted in alginated PBS solution. For each cell experiment, a syringe pump was used to 
inject the cell solution at a prescribed flow rate. 1 mL PBS solution was then injected to 
remove all suspended cells at a flow rate of 3.5 mL/h. For long-term imaging, all 
captured cells were fixed by 4% paraformaldehyde for 15 mins at RT and then kept at 
4 °C. All microfluidic devices were then imaged by a regular microscope to count 
captured cells. 
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3.4 Results and Discussion 
3.4.1 Numerical Model 
 Figure 3-1(a) shows a COMSOL simulation results for a typical herringbone 
microfluidic chip. The flow streams were disturbed by the asymmetric grooves, which is 
essential for cell-surface interactions and further cell capture. More clearly illustrated in 
Figure 3-1(b), the vortex effect in the cross-section was critical to shift flowing cells 
towards the antibody coated capture bed. This chaotic effect was also widely 
demonstrated experimentally and numerically by studying the mixing of fluorescent and 
clear solutions [56, 109]. Figure 3-1(c) outlined all geometric parameters in a herringbone 
unit. To perform a comprehensive geometric study, each parameter was carefully 
considered within a specified range. The basic criterion for selecting values for a 
parameter was to cover as many possibilities as possible and refer to the trend of the 
numerical results. More details can be referred to the section of Geometric Optimization. 
Figure 3-1(d) describes a scenario where a flowing cell contacts the capture bed. Based 
on the adhesion probability, cells were determined either to keep firmly captured or 
detach. Specifically, a random between 0 and 1 was generated upon a cell contacted the 
capture bed. Meanwhile, the adhesion probability P for the cell was also calculated 
following eqn. (3-5). If P was larger than the random number, the cell was treated to be 
firmly captured. Otherwise, the cell was treated to be transiently tethered and continued 
to flow following the governing equation. 
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 To determine the adhesion probability for a flowing cell, unknown A and B in eqn. 
(3-5) should be evaluated first. Notably, different cancer cell types have varied 
biomolecule characterizations, which make A and B unique for each cancer cell line and 
each test condition with different antibody coating density. In this study, HCT-116 cells 
and an anti-EpCAM coating density of 10 µg/mL [68-69] were investigated. As described 
in the section of Numerical Methods, experiments combined with corresponding 
simulations were used to calculate A and B. As for B, since it reflects the adhesion 
probability under different shear stresses, a cell capture experiment was performed to 
extract B in a Hele-Shaw microfluidic chip, where the shear stress decreases linearly 
along the flow direction [107, 110]. Figure 3-2(a) shows the linearly decreasing shear 
(a) (b) 
Figure 3-1 (a) Typical flow domain of one unit in a herringbone microfluidic chip 
simulated by COMSOL. (b) The chaotic flow pattern for enhanced cell-surface 
interactions in a cross-section. Schematic diagrams of a herringbone unit with all 
annotated geometrical parameters from (c) top view and (d) side view. A scenario of 
flowing cell to be firmly captured or not determined by adhesion probability is 
illustrated in (d). 
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stress along the flow direction. The microfluidic chip was divided into multiple parallel 
sections along the flow direction with a width of 1 mm. The shear stress in the middle of 
each section was used as the average value. The amount of captured cells in each section 
was counted and normalized to the one in the last section where the shear stress was the 
smallest. Figure 3-2(b) shows an exponential fit of B following the format of eqn. (3-5). 
Based on the data fit, B was calculated as 7.3. 
 
 As for A, it reflects the magnitude of adhesion probability under a certain shear 
stress. Specifically, the intrinsic ability for a cell to be firmly captured is positively 
proportional to A. To calculate A, we introduced a ridge-bottom ratio of amounts of 
captured cells which considered the capture performance on both groove ridges and 
groove bottoms. Cell capture experiments were first performed and captured cells on both 
groove ridges and groove bottoms were counted to calculate the ridge-bottom ratio. As 
(a) (b) 
Figure 3-2 (a) A Hele-Shaw design with shear rate linearly decreasing along the flow 
direction ; (b) Normalized cell amount along the flow direction. The channel is 
divided into equal sections with a microscope window width of 1 mm. Cell amounts 
in continuous microscope windows are normalized by the average of cell amount in 
the last window section where the shear rate is the smallest. Error bars stand for 
standard derivation from five independent windows in each cross-section. An 
exponential curve fit is then applied to obtain the value of B. 
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shown in Figure 3-3(a), this was repeated at four different shear rates which covered the 
range widely used in literature [35, 76]. On the other hand, attempts of numerical 
simulations to match with the experimental results were taken by substituting A of 
different values ranging from 0.01 to 500. For each A, ridge-bottom ratios at these four 
shear rates were calculated. The least square method was then used to calculate the sum 
of squared residuals between the numerical results and experimental results, as shown in 
Figure 3-3(b). It reveals that with increasing A, the overall trend of the error decreases 
first and then increases. The zoom-in image shows that the minimum error happens when 
A equals to 3.0. In other words, A with a value of 3.0 best reflects the real experimental 
condition. To be noted, Figure 3-3(b) also suggests that A smaller than 0.01 or larger than 
500 leads to larger errors, thus these values were not tested. 
 
 By substituting both A and B to eqn. (3-5), the adhesion probability was 
simplified to be only dependent on the shear stress which was a function of the cell 
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Figure 3-3 (a) Comparison of the ridge-bottom ratio of the captured cell amount 
between experimental and numerical results under various attempts of A ranging from 
0.01 to 500. (b) The error calculated by the least square method under different A. The 
zoom-in image shows the optimized value for A where a smallest error exists. 
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position. As a result, a numerical model of cell dynamics integrated with adhesion 
probability was built and used for the geometric optimization study as detailed below. 
3.4.2 Geometric Optimization 
 As shown in Figure 3-4(a), the capture efficiency slightly changes with the 
increasing number of the grooves, reaching the plateau after 6. In Figure 3-4(b), with 
increasing groove intersection angles, the capture efficiency first increases and then 
decreases in the turning point between 90o and 120o. The maximum capture efficiency 
happens at the groove angle of 90o, where the stretching and folding of transverse flow 
reaches maximum thus generating significant mixing effects. 
 
 In Figure 3-5(a), h/r and d/h act differently on capture performance: capture 
efficiency decreases with increasing h/r, while it increases with increasing d/h and 
reaches a plateau after 1. This is explained as follows: with increasing h/r, the increasing 
free space for cell travel and relatively reduced chaotic effects allow for less cell-surface 
(a) (b) 
Figure 3-4 Numerical results of normalized capture amount under (a) different 
number of grooves per half cycle and (b) different groove intersection angles. 
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interactions. On the other hand, with d/h increasing in the range of 0.2-1, the chaotic 
effect in the cross section can be enhanced, thus bringing more cells towards the capture 
bed. The interesting fact happens in the range of 1-4 where increasing d/h has little effect 
on the capture performance, which is speculated as the result of rare influence of the flow 
field induced by the extremely large hydraulic resistance in the groove bottom. In Figure 
3-5(b), capture efficiency decreases with the increasing width periods, where the longer 
transverse travel distance weakens the mixing effect. Meanwhile, the increasing 
percentage of the short arm is shown to increase the capture efficiency, which is different 
from the result in literature where d/h of 1/3 is optimized for mixing. This significant 
difference is attributed to the fact that although asymmetric geometry can enhance the 
transverse flow thus increasing the mixing effects, it does not necessarily indicate 
enhanced cell-surface interactions. In other words, mixing effect is an overall term to 
evaluate the flow domain, while the cell capture only occurs close to the wall which 
cannot be determined by the overall flow pattern. This explanation again supports the 
view that mixing effect cannot be directly adopted to optimize the geometry for enhanced 
cell capture and an explicit model is needed for the geometry design. 
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 In Figure 3-6(a), for a specific groove pitch, the overall trend of capture efficiency 
with increasing groove percentage is first increasing and then decreasing. This trend is 
explained by the trade-off of hydraulic resistance in the groove region and the channel 
planar region as shown in Figure 3-1(d). The hydraulic resistance is calculated as 
28 hR L R A  in a channel with a rectangular cross-section. The hydraulic resistances in 
the groove section and the corresponding channel section can thus be calculated as 
 
2
3 38 eff g g g gR L w d w d   and  
2
3 38 g eff effR w w h w h  , respectively. Take the 
groove pitch of 200 μm as an example, as shown in Figure 3-6(b). Two different regimes 
are existed divided by the intersection point where hydraulic resistance in the groove 
region and the channel planar region are balanced: in regime I where hydraulic in the 
groove region is larger, with increasing trough widths, the rotational flow in the vertical 
direction is enhanced, thus increasing the cell deflection and cell-surface interactions; in 
regime II where hydraulic in the channel region is larger, with increasing trough width, 
(a) (b) 
Figure 3-5 (a) Numerical results of normalized capture amount under different 
channel widths and different asymmetrical factors. (b) Numerical results of 
normalized capture amount under different channel heights and different groove 
depths. 
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the continuously decreasing hydraulic in the groove region allows more cells freely flow 
in the groove region with less cell-surface interactions due to the decreased cell 
deflection effect. Given the mechanism, the trend of capture efficiency exactly follows 
the transition of regime I to regime II, where regime I dominates in the range of 0.1-0.5 
while regime II in the range of 0.5-0.9. 
 
 To unravel the capture efficiency in a specific microfluidic device, it is essential 
to understand the cell-surface contact frequency in different areas. Specifically, the 
higher the cell-surface contact frequency, the larger chance for a cell to be captured. A 
HB microfluidic device is divided into four different sections where the cell-surface 
contact frequency is calculated respectively, as sketched in Figure 3-7(a). Given the fact 
that a few recent studies indicated the critical role of the groove asymmetry in 
determining the CTC purity performance which is another important criterion in 
(a) (b) 
Figure 3-6 (a) Numerical results of normalized capture amount under different groove 
pitches and groove widths. (b) Theoretical hydraulic resistance calculated for both the 
bottom groove and the upper plain channel in a herringbone microfluidic chip with a 
groove pitch of 200 μm. The intersection point indicates a flow resistance balance 
between the groove and the plain channel. 
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designing a microfluidic device [55], the effect of the groove asymmetry is of special 
interest in this study. Figure 3-7(b) shows the cell-surface contact frequency in the 
prescribed areas under various groove asymmetric factors. The overall trend of the total 
contact frequency agrees well with that of the capture efficiency, which first increases 
and then decreases with increasing asymmetric factors. Furthermore, it suggests that cells 
have the largest chance to contact with the groove ridge. In the respect of designing 
optimized microfluidic chips, it will be most effective if any strategy is introduced to 
enhance cell capture in the groove ridge section. For example, since nanostructures was 
found to enhance the CTC capture due to the increased cell-surface contact area, an 
integration of nanostructures on the groove ridge can contribute most to the enhanced 
CTC capture. Especially in certain situations where difficulties lie in fabricating 
nanostructures uniformly over the groove-HB structures [111], a local integration of 
nanostructures on the groove ridge can suffice. 
 
Figure 3-7 (a) Schematic diagram of a herringbone microfluidic chip from the side 
view. The channel surface is divided into four sections marked in different colors. (b) 
Numerical results of cell-surface contact frequencies in different sections under 
different groove widths with a fixed groove pitch of 160 μm. 
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3.5 Conclusion  
 We present an explicit computational model integrated with adhesion probability 
to investigate geometric effects on tumor cell capture performance for a HB microfluidic 
device. To evaluate the adhesion probability for specific cell lines and antibody coating 
conditions, two sets of microfluidic experiments combined with corresponding 
simulations are used to extract two lumped parameters which directly determine the 
adhesion probability. In this study, HCT-116 cells and 10 μg/mL anti-EpCAM coating 
condition were used an example to demonstrate the approach to determine these two 
lumped parameters. By using the developed computational model, a better understanding 
of geometric effects on tumor cell capture was achieved for a hallmark HB microfluidic 
device. Most significantly, the results suggest a short arm ratio of 0.5 for optimized tumor 
cell capture which is against from 1/3 obtained from most studies [56, 112]. This 
difference is attributed to the intrinsic difference between particulate cell model and pure 
mixing model. Specifically, our model integrates the particulate cellular properties, while 
most works in literature [112-114] only reply on the mixing effect to design a HB 
microfluidic device for CTC capture which cannot directly reflect the cell-surface 
interactions. As a result, this improved computational model can provide a more accurate 
and reliable geometric design criterion for optimized tumor cell capture in microfluidic 
devices. One limitation on the current model lies in the neglect of cell-fluid interactions 
which are also important in determining cell motions in the scale of most tumor cell 
capture microdevices [104-105]. A more comprehensive model will be implemented in 
our future work.  
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Chapter 4: Geometric Effects of 
Nanopillars for CTC Capture 
 
4.1 Introduction  
 Circulating tumor cells (CTCs) are cells that shed from a tumor mass and 
circulate in peripheral blood. Detection and analysis of CTCs can guide cancer diagnosis, 
prognosis and treatment [84, 115-116]. Isolation of CTCs from patients' blood attracts 
significant attention as a first step toward CTCs analysis. A variety of techniques have 
been developed in the past decades, which rely mainly on physical properties (e.g., size, 
density and deformability) [117-119] or expressions of biomarkers [30, 43, 120-122]. 
However, most of these methods failed to show clinical validity or utility, thus remained 
in the laboratory settings due to their limited isolation efficiency and the rarity of CTCs, 
i.e., as few as 1 CTC per 1 mL peripheral blood. Therefore, improvement of CTC 
isolation efficiency and specificity is a pressing issue. 
Recently, nanostructured substrates have emerged as a promising CTCs detection 
and isolation platform since they can provide high isolation efficiency (80-95%, normally 
~90%) [123-127]. The cell-nanostructure interaction has also been reviewed 
comprehensively and several basic design principles has been delivered [23]. For the 
selection of nanomaterials, silicon nanomaterials are a good candidate for CTC study due 
to their biocompatibility and unique electronic properties [24]. Compared to flat surfaces, 
nanostructured substrates provide larger surface area for the immobilization of anti-
epithelial cell adhesion molecule (anti-EpCAM), increasing the binding odds between 
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antibody and membrane receptor and also total binding forces, thus enhancing CTC-
isolation efficiency. Moreover, the natural extracellular matrix or basement membrane 
mimicking nanostructured substrates offer a suitable environment for CTCs attachment. 
In previous studies, nanostructures with size ranging from 30 to 1150 nm have been 
employed for CTCs isolation, and high efficiency was reported in all cases. For instance, 
88% of cancer cells were captured onto antibody immobilized silicon nanowires (SiNWs) 
with diameter of 50-160 nm [128]; high isolation efficiency up to 95% was reported on 
antibody grafted silicon nanopillars (NPs) with diameter in the range of 100-200 nm [39]; 
cancer cell isolation efficiency on antibody grafted spherical particles with diameter of 
232 nm was 4-5 times higher than on a flat surface [129]. Nanostructured surfaces with 
halloysite nanotubes was also demonstrated to enhance the CTC recruitment with a three-
fold increase for MCF7 cells, while nonspecific leukocytes adhesion was prevented [130]. 
Meanwhile, efficient CTC capture with high selectivity has also been reported by using 
functionalized graphene oxide nanosheets [131] or soft polystyrene nanotube substrates 
[132]. Recently, developing multifunctional platforms modified with nanostructures 
comes to be of significant research interests for biomedicine applications. A 
nanodendritic silica coating has been developed to not only efficiently capture CTCs, but 
also own the ability to directly monitor the results due to its transparency under water 
[133]. Controlled CTC release after cell capture has also aroused more attention since it is 
very important for subsequent cell analysis [134]. A thermoresponsive substrate with NPs 
was developed to capture targeted CTCs and then release CTCs in a prescribed manner 
[135]. Efficient CTC capture and release process has also been achieved by using 
programmable fractal gold nanostructures through an electrochemical method [136]. 
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Nevertheless, preferred nanostructure geometry is still unclear for CTCs isolation. A 
quantitative study of the relationship between capture efficiency and nanostructure 
geometry is necessary for the optimization of substrate topographical design for CTC 
isolation. At the same time, morphology of captured cancer cells on nanostructured 
substrates is not conclusive either. In previous reports, the captured cells were found to be 
flatter on aptamer grafted nanostructured substrates than that on planar surfaces: cells 
changed from a globular shape to a semielliptical one [30, 137]. The flatter shape of 
captured cells indicated that more receptors on the cell membrane make contact with 
immobilized antibodies; meanwhile, the decreased cell height further prevented them 
from being eluted under high shear stress [137]. Contrarily, it was reported that the high 
aspect ratio of bare SiNWs and polystyrene (PS) NPs support cell adhesion but restrict 
cell spreading due to insufficient area for development of micron-scale focal adhesion 
[138-139]. Furthermore, nanostructured substrates may also influence the pseudopodia 
formation. Captured cells showed either significant lamellipodia or filopodia on 
nanostructured substrates with certain aspect ratios [140].  
In this study, we investigated the effects of NP geometry on cell capture yield, 
cytomorphology and pseudopodia formation. Capture yield is defined as the ratio of cells 
captured on the NP substrate to total number of cells initially loaded. Our results showed 
that capture yield is linear to effective contact area of the NP substrate. Dense NPs with 
smaller diameter yield larger effective contact area, thus were preferred.  However, once 
the spacing between NPs was smaller than the size of a microvillus (<100 nm) or was too 
large (>800 nm), cell capture yield and specificity were significantly impaired. We also 
confirmed that the formation of either lamellipodia or filopodia correlates with adhesion 
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status and eluting strength. Specifically, under the same shear stress, lamellipodia were 
generally formed on NPs with high aspect ratio (>10) where captured cells were firmly 
attached; furthermore, significant filopodia formation was observed on NPs with low 
aspect ratio where captured cells were more prone to detach, indicating filopodia might 
obtain newborn adhesive force to resist shear stress mediated detachment [141]. 
4.2 Experimental Details 
4.2.1 Fabrication of Silicon Wafers Covered with NPs 
 Silicon wafers covered with NPs with different diameters were fabricated by 
metal assisted chemical etching [142]. In detail, the silicon surface (Si (100), B-doped, 
0.004-0.007 Ωcm) was cleaned by a RCA-I approach. Deionized water, ammonia 
solution (25%) and hydrogen peroxide (30%) were mixed in ratio of 5:1:1. The solution 
was heated up to 80 degrees and silicon chips were cleaned for 15 mins. Afterwards 
nanospheres (polystyrene (PS) with diameters: 1.39 µm, 722 nm and 390 nm) were 
deposited by a modified Langmuir-Blodgett technique in monolayer for lithographic 
structuring. In the next step the PS-spheres were etched in O2-plasma to reduce their 
diameters. Following silver (30-60 nm) was evaporated onto the surface. PS-spheres were 
lifted off by dichlormethane in an ultra-sonic bath and the chips were rinsed with acetone, 
ethanol and deionized water. Thus a metal film on silicon with specific openings was 
created. The size of the openings correlates with the size of the plasma-etched PS-spheres. 
After that etching in a hydrofluoric acid and hydrogen peroxide based solution was 
carried out. The solution consists of 37 mL deionized water, 12.5 mL hydrofluoric acid 
(40%) and 0.5 mL hydrogen peroxide. The chips were etched for 5 mins. The metal film 
sinks into the silicon, which is solved by the etching solution. In the end, around 1 µm 
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long NPs were obtained and silver was removed by concentrated nitric acid for 2 mins. 
The diameter of the NPs is equal to the size of the opening in the metal film and is also 
equal to the diameter of the PS-spheres after plasma-etching. Finally, 5 x 5 mm wafer 
substrates with NPs of diameter ranging from 120 nm to 1100 nm were attained.  
4.2.2 Surface Functionalization of Anti-EpCAM 
 Prior to the surface functionalization, all the wafer substrates were washed using a 
three-step cleaning process (acetone, isopropyl alcohol and DI water), and dried under 
nitrogen [120]. Then, wafer substrates were fixed in 35x10 mm petri dishes and treated 
with oxygen plasma to confer the hydroxyl groups on the substrate surface. In order to 
chemically modify the substrate, a three-step surface functionalization process was 
immediately applied. They were firstly pretreated with 5% (v/v) 3-mercaptopropyl 
trimethoxysilane in ethanol for 30 minutes at room temperature (RT), followed by 
incubation with 0.01mM N-y-maleimidobutyryloxysuccinimide ester (GMBS) in 200 
proof ethanol for 30 minutes at RT. NeutrAvidin was then immobilized to GMBS by 
incubating the substrates with 10 µg/ml NeutrAvidin in phosphate buffered saline (PBS) 
overnight at 4oC. Within 24 hours of the experiment, 10 µg/ml biotinylated goat 
antihuman EpCAM solution in PBS containing 1% (w/v) bovine serum albumin (BSA) 
were added to the substrate for 2 hours at RT. After each reaction, PBS or ethanol, 
depending on the solvent used in the previous step, was used to remove unbounded 
molecules. One hour prior to running the cell test, the substrates were purged with 3% 
BSA with 0.05% Tween20. 
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4.2.3 Cell Culture and Cell-test Sample Preparation 
 PC3 prostate cancer cells was selected as an appropriate platform for optimization 
study of capture of CTCs, as lower concentration of EpCAM, namely 51667 molecules 
per cell, was expressed for PC3 cells [120]. PC3 cells were cultured at 37 oC in 5% CO2 
in F-12K growth medium containing 1.5 mM L-glutamine supplemented with 10%  fetal 
bovine serum (FBS) and 1% Penicillin/Streptomycin with media change every 2-3 days. 
Cells were then released through incubation in 0.05% Trysin-0.53 mM EDTA at 37oC 
for around 5 minutes. Hemocytometer was used to count cells and according dilution was 
subsequently pursued to reach a cell concentration around 105/mL [128]. The cell 
concentration was selected also for ensuring the yield of a large result data pool to reach a 
reliable conclusion. 
4.2.4 Cell-capture Yield Test and Cell Detachment Test 
 For the cell-capture yield test, 20 µL of cell solutions was added to the wafer 
substrates and immediately followed by incubation at 37 oC in 5% CO2 for different 
incubation time mentioned in the manuscript. Next, 2 mL of PBS buffer solution was 
added to the petri dish, which was then fixed on the shaker. Different shaking speeds and 
different lasting time were applied to detach PC3 cells, followed by removing all 
suspensions. Both regular microscope and scanning electron microscopy (SEM) were 
applied to analyze the results including cell amount, geometry and morphology. 
 For SEM specimen preparation, a standard procedure reported in our previous 
work [137] was followed. Briefly, Cells were firstly fixed with 4% paraformaldehyde at 4 
oC for 1 hr. Next, paraformaldehyde was removed and cells were rinsed by PBS buffer 
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solution twice. Cells were then dehydrated in ethanol with a concentration gradient of 
20%, 30%, 50%, 70%, 85%, 95%, and 100% (15 minutes in each solution). After 
treatment of 100% ethanol, all cell samples were lyophilized overnight. Finally, 
dehydrated cells were sputter coated with gold and imaged by Zeiss 1550 SEM. Images 
of cells from both upright view and tilted view were scanned for post-analysis. 
4.2.5 Quantitative Analysis of Cell-capture Yield, Cell Morphology and 
Substrate Wettability 
 To calculate cell capture yield, SEM images were taken section by section 
throughout the whole substrate and amount of captured cells was then counted. As for the 
quantitative analysis of cell morphology, SEM images of top view were used for 
calculating the apparent contact area by tracing the boundary of captured cells using 
ImageJ software (NIH). Meanwhile, SEM images of tilted view were used for measuring 
the height of the captured cells, which was modified by the tilted angle of the stage (80 
degrees). For each SiNP substrate type, 20 cells that were well separated from other cells 
were measured. Furthermore, wettability of functionalized and non-functionalized 
substrates was evaluated by measuring their contact angles. 1.5 µL, 3 µL and 4.5 µL of 
water droplet was added to the substrates and images were then analyzed using "contact 
angle" plug-in in ImageJ. 
4.2.6 Calculation of Maximum Displacement of One Individual NP 
 For one individual NP with diameter of 120 nm, it endures both focal complex 
force (0.8-0.9 nN/µm2) [143] and ligand-receptor bond force (
66.7 10 dyn  for one bond) 
[144]. Focal complex force was applied in the top surface of NP and ligand-receptor bond 
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force in both top surface and side wall. Following this boundary setup, an FEM study 
using Comsol software was pursued to study the maximal displacement.  
4.2.7 Study of Substrate Wettability through Cassie's Law 
 In our NP substrate system, with the fact that the substrate surface was silicon 
dioxide which was hydrophilic, the Cassie's law gave the  contact angle θ as 
1 1 2 2cos cos cosf f     , where 1f  and 2f  are the fractions of the solid phase (namely 
packing density of NPs) and water phase which compose the entire surface, respectively. 
1  and 2  are contact angles for the solid phase and water phase, respectively. Noticed 
2 0   for water phase. So the equation of contact angle θ were simplified as: 
 1 1 1arccos cos 1f f    . 
4.3 Results and Discussion 
4.3.1 Fabrication and Characterization of NP Arrays 
 Anti-EpCAM coated NPs with diameter ranging from 100 to 1100 nm, spacing 
ranging from 30 to 800 nm, and fixed height of 1 µm were prepared. A schematic of the 
fabrication process and a tilted SEM image of fabricated NPs are shown in Figure 4-1(a) 
and 1(b), respectively. The average diameter, spacing and standard deviation (SD) of 
each group (n=30) are summarized in Table 4-1. The variations of diameter and spacing 
from each group are within 2-8%, arising from the size distribution of PS-spheres and 
different O2 plasma treatment time. To avoid truncated cone structures or collapse of NPs 
all groups were etched for 5 minutes only, and thus NPs with same length of 1 µm were 
obtained. 
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Table 4-1 Geometrical Properties of NP arrays. Different groups are named as "NP" 
followed by their average diameters. 
Group Diameter of NPs 
[nm] 
Spacing  
[nm] 
NP120 118.2±9.4 154.3±17.5 
NP200 204.8±7.3 154.9±14.9 
NP300 292.7±11.3 38.7±2.5 
NP550 571.5±36.5 144.0±10.5 
NP650 649.6±38.1 797±126.1 
NP1100 1147.8±23.1 189.2±25.0 
 
 
We first characterized various NPs' compliance, packing density and wettability. 
Bending compliance affects the adhesion, spreading and migration of attached cells [140, 
145], and was calculated as: 
 
3
4
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ED
                     (4-1) 
where h and D are the height and diameter of NPs, respectively; E is Young's modulus of 
NPs with a value of 70 GPa [146]. Figure 4-1(c) shows NPs with smaller diameter yield a 
larger compliance, indicating a potential of a larger deformation. As such, NP120 with 
smallest diameter were considered for deformation analysis. When an individual NP120 
is subjected to both focal complex force (0.8-0.9 nN/µm2) [143] and ligand-receptor bond 
force (
66.7 10 dyn  for each bond [144] and approximately 51667 EpCAM per PC3 cell 
[31]), its maximal tip displacement is 0.0046 nm (Figure 4-1(d)). With such negligible 
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deformation, all NPs were considered as rigid. SEM images further confirm that most of 
NPs stand straightly (Figure. 4-3(b-c) and Figure 4-6(f-g)). With a hexagonal NP array, 
packing density   was calculated as: 
 
2
3
12 1 g
D
D

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 
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 
                    (4-2) 
where 
gD  is the spacing between two neighboring NPs. As shown in Figure 4-1(c), NPs 
with larger diameter were more densely packed. For comparison purpose, a denser 
( 0.71  ) and a sparser ( 0.18  ) packing pattern were obtained from NP300 and NP650, 
respectively, due to their extraordinary spacing (Table. 1). We then investigated the 
wettability of NPs by studying the contact angles of water droplets on substrates. On a 
heterogeneous surface, nanostructured patterns have been reported to enhance surface 
hydrophobicity or hydrophilicity [147]. As a result, SiNP substrates were enhanced to be 
superhydrophilic due to its hydrophilic nature of oxidized surface in air with contact 
angle less than 10°. The measurement results are well fitted with the values calculated by 
applying Cassie's law (Figure 4-1(e) and see Supporting Information S2 for more details). 
It should be noted that surface functionalized with antibodies insignificantly increased 
wettability due to the inherent superhydrophilic property of NPs.   
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Figure 4-1 (a) Fabrication process of NP arrays by metal assisted chemical etching 
method. (b) A typical SEM image of NP arrays with average diameter of 650 nm from 
tilted view. The inset in (b) shows the magnification of NPs from tilted view. (c) 
Mechanical and geometrical properties of NP substrates: compliance and packing 
density. (d) A finite element method (FEM) analysis of a single bending NP showing the 
displacement of an NP with diameter of 120 nm. The unit of the color bar is nanometer. 
(e) Wettability of different NP substrates before and after functionalization. The solid line 
and dashed line stand for fitted curves using Cassie's law for non-functionalized and 
functionalized NP substrates, respectively. Error bars in (e) stand for standard derivation 
from three independent experiments. 
 
4.3.2 Selection Criteria for Incubation Time and Shaking Speeds 
 As shown in Figure 4-2(a), incubation time ranging from 5 mins to 2 hrs was 
applied with 10 mins' shaking in 60 rpm. It was observed that, for bare wafers with anti-
EpCAM coated, capture yield increased with incubation time, reaching a plateau of 22.9% 
in 1 hour. No significant difference of capture yield was observed after 1 hour, with 23.1% 
and 24.4% for 90 minutes and 120 minutes, respectively. Rare capture for bare wafer 
with 1% BSA coated verified that capture of PC3 cells in anti-EpCAM group was 
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induced by specific bonds between PC3 cells and anti-EpCAM. Moreover, aim of this 
work is to study cell capture other than cell adhesion/migration, so that focal adhesions 
fully established in around 1 hr [143] was not considered in our case. Timescale of 1 hour 
was also widely adopted in other relative work [125]. With these, 1 hour of incubation 
was applied for all the following studies. As shown in Figure 4-2(b), shaking speeds 
ranging from 60 rpm to 400 rpm were applied after 1 hour's incubation. The relationship 
between maximum orbit shear stress and shaking speed was expressed as:
 
3
max 2o a f   , where, a  and f  are orbit radius (0.95 cm) and frequency 
(rotation/sec depending on shaking speeds) of the rotation of the shaker, respectively;   
(0.90 mPa·s) and  (0.995 g/mL) are dynamic viscosity and density of the medium, 
respectively [148]. As such, shaking speed between 60 rpm and 400 rpm corresponds to 
orbit shear rate between 157.3/s and 2708/s, which covered the majority range reported in 
literature: 267/s-1067/s [121] and 83/s-1166/s [149]. As expected, due to increased shear 
stress, capture yield decreased with increasing shaking speed and the biggest capture 
yield was obtained in the shaking speed of 60 rpm. The calculating shear stress of 0.24 
dyn•cm-2 in 60 rpm was also observed to achieve more than 95% capture yield in a 
previous study [149]. Rare capture for bare wafer with 1% BSA coated again verified that 
capture force was generated by the specific bond between PC3 cells and anti-EpCAM. It 
also indicated that 60 rpm was enough to elute suspended cells. As a result, the optimal 
shaking speed of 60 rpm was adopted for all the following studies. 
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Figure 4-2 Quantitative evaluation of capture yield for cases with 1% BSA coated and 
with anti-EpCAM coated (a) at different incubation times followed by 10 minutes of 
shaking in 60 rpm and (b) after 1 hour of incubation followed by 10 minutes of shaking 
under various shaking speeds. Each error bar represents a standard derivation and is 
obtained from three independent experiments. 
 
4.3.3 Spacing and Diameter Effects of NPs on Cell Capture Yield and 
Cell Behaviors 
 The cell-NPs incubation time and orbit shear stress for eluting were optimized on 
planar wafers first (see Supporting Information S3 for more details), and the selected 
conditions were applied throughout the study in all NPs groups. The capture yield 
reached plateau after one hour (Figure 4-2(a)). Shaking at 60 rpm for 10 minutes 
effectively detached nonspecifically attached PC3 cells while maintaining the maximal 
capture yield (Figure 4-2(b)).  
With the proper experimental conditions determined, we next examined spacing 
effects on capture yield and cell behaviors. Figure. 4-3(a) shows the average diameter of 
a microvillus was 105.8 ±14.8 nm measured from zoomed-in SEM images of a single cell 
sitting on a bare wafer, which is in agreement with previous reports [150]. 6 NPs groups 
were thus divided into 3 different categories: NP300 with extremely small spacing (~40 
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nm), NP650 with extremely large spacing (~800 nm), and the remaining 4 groups with 
approximately similar spacing (140-190 nm). Low capture yield of 24.3%±6.3% was 
found in NP300 group, which was close to 22.9% obtained on a planar wafer (Figure 
4-4(a)). We speculate that such low capture yield is likely due to the small spacing that 
prevents microvilli or pseudopodia from penetrating through the gap and contacting with 
the lateral surface of NP300. Thus cells were unable to gain sufficient adhesion force to 
resist the following eluting shear stress. As cells only contacted with the top surface of 
NP300 (Figure. 4-3(b)), cells on NP300 showed a globular shape which was unlike the 
flat cell morphology in other groups. On the contrary, cells showed a very flat shape on 
NP650, where microvillus or pseudopodia easily filled into the 797 nm spacing (Figure. 
4-3(c)). Compared to cells on NP300 these cells had larger contact area and gained bigger 
adhesion force. Hence, relatively higher capture yield of 46.95%±18.7% was obtained on 
NP650; however, due to its sparse packing pattern (Figure 4-1(c)) and relatively smaller 
effective contact area (discussed later), capture yield on NP650 was still low (Figure 
4-4(a)) in comparison to NP120 and NP200. The significantly higher SD on NP650 was 
also likely to be caused by larger spacing in which cells can physically situate in various 
ways. Thus, the nonspecific settlement may contribute to the large capture yield 
fluctuation. In the remaining 4 groups with 140-190 nm spacing, cells spread moderately 
and effectively interacted with NPs’ lateral walls (Figure. 4-3(d)); the capture yield 
ranged from 28.0% to 80.8% along with the increased effective contact area of each 
group (discussed later). The above results indicated that spacing is an important factor 
that is directly related to capture yield. Dense NPs with very small spacing (~ 50 nm) 
adversely impairs cell capture yield. In one previous study, dense silica bead (diameter 
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ranges from 100 to1150 nm) were deposited closely onto a glass slide without any 
spacing, cell capture yield was only 1.2-1.6 times higher than that on a planar surface 
[151]. This result also indicates the spacing plays an important role in capture yield. On 
the contrary, increased nonspecific settlement may appear on sparse NP surface when the 
spacing is larger than 500 nm, i.e., diameter of filopodia. Considering the spacing of 
NP120 and its over 80% capture yield (Figure 4-4(a)), 140-200 nm spacing probably well 
suits the needs of efficient and specific capture.  
 
Figure. 4-3 (a) Zoomed-in and zoomed-out SEM images reveal details of microvilli on 
the cell membrane. (b)-(d) Cell behaviors in NP substrates with a spacing of 38 nm for 
NP300 in (b), 790 nm for NP650 in (c), 140 nm for NP550 in (d). All cells were 
incubated for 1 hr followed by 10 mins of shaking in 60 rpm. 
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We then examined the effects of diameter of NPs on capture yield and cell 
behaviors. In the remaining 4 groups, diameter of NPs was considered as the major 
varying factor. The spacing ranged from 144.0 nm to 189.2 nm with the maximal 
difference 45.2 nm was smaller than the diameter of a single microvillus, thus was treated 
as a minor factor here. The average spacing of 160.6 nm (SD: 19.7 nm) of the 4 groups 
was generally adopted for the following studies and discussion. Figure 4-4(a) shows that 
capture yield decreased with increasing diameter of NPs, reaching 28.0%±3.9% in 
NP1100 group which was almost the same as that in planar wafer case (22.9%). We 
explained this trend by adhesion strength induced by NP-cell interaction and thus 
introduced two parameters: apparent contact area
 a
A  and effective contact area
 e
A . aA  
was defined as the projection area of a captured cell from top view; eA  was defined as the 
area of the NP substrate with chances to touch the captured cell. It was calculated as the 
whole surface area of the NP substrate consisting of top, lateral and bottom surfaces 
beneath the captured cell as shown in Figure 4-4(b). This is because microvilli (diameter: 
100-120 nm; length: 2-4 µm) and filopodia (diameter of 100-500 nm; length from few 
microns to ˃50 µm) can fit into the spacing of NPs, and can even reach the bottom of the 
substrate. Through SEM images of the captured cells, we measured apparent contact area 
aA  (Figure. 4-3(a)) and cell height (Figure 4-4(b)) from top and tilted view, respectively, 
and summarized in Figure 4-4(c); all data points were well fitted by a rectangular 
hyperbola, indicating that estimating the average volume of cells as a simplified cylinder-
like shape was consistent in each group. According to the definition of effective contact 
area, eA  
was further calculated as: 
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Figure 4-4 (a) Cell capture yield measured on substrates with different diameters of NPs 
after 1 hour of incubation and 10 minutes of shaking in 60 rpm. (b) Schematics (not in 
scale) of a captured cell on an NP substrate with red bold line marked as the effective 
contact area, and a typical SEM image of a captured cell on NP1100 from tilted view. (c) 
Cell morphology consisting of cell height and apparent contact area for different NP 
substrates. The inset of (c) shows apparent contact areas for NP substrates with various 
diameters and planar wafer. (d) Cell capture yield measured on NP substrates with 
various diameters and planar wafer. The inset in (d) shows effective contact areas for NP 
substrates with various diameters and planar wafer. The solid line in (d) stands for a 
linear fit. Error bars for capture yield in (a) and (d) stand for standard derivation from 
three independent experiments. Error bars in (c) stand for standard derivation from 20 
arbitrary cells' measurements. 
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Figure 4-4(e) showed eA  decreased with increasing diameter as expected, 
indicating NPs with smaller diameter have larger surface area. Figure 4-4(d) revealed that 
capture yield decreased linearly with decreasing eA . Furthermore, the linear function also 
applied to planar wafer and NP300 cases, where eA  is exactly or approximately equal to 
aA . However, the linear function did not apply for NP650, mainly due to cells’ 
nonspecific settlement as discussed above. Contrarily, we did not observe an apparent 
relationship between capture yield and aA  
(Figure 4-5). It was concluded that 
nanostructured surfaces can provide larger surface area for enhanced antibody 
immobilization; larger antibody functionalized area can significantly increase the odds of 
antibody-receptor binding and thus the cell capture yield [123]. Another previous report 
also validated that cell capture yield can be improved by increasing the total area of gold 
clusters on SiNWs for antibody immobilization [128]. Nevertheless, we clearly showed 
for the first time that capture yield was linearly associated with eA  instead of aA  on 
substrates with nano-patterns. Therefore, with suitable spacing of 140-200 nm, higher 
capture yield can be obtained with smaller NPs of larger surface area for more antibody 
immobilization.  
In addition to the effects of diameter of NPs on capture yield, we also observed 
different cell morphologies and spreading effects on antibody-coated NPs with different 
diameters. First of all, cells had relatively flat shape on the remaining 4 NPs groups 
(Figure 4-6). As shown in Figure 4-4(c), we observed an overall decreasing of aA  and 
increasing of cell height with increased NPs diameter. As a result, captured cells were 
able to endure higher shear force on smaller NPs, thus leading to higher capture yield. 
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Our previous work has also verified that decreased cell height further prevented captured 
cells from being washed away under high flow velocity [106]. Additionally, the inset of  
Figure 4-4(c) shows that antibody-coated NPs did not necessarily inhibit the cell 
spreading compared to planar wafers, which is different from a previous study [139]. In 
our previous report, epidermal growth factor receptor (EGFR) overexpressed cancer cells 
became flatter and reshaped to cover as large of an anti-EGFR aptamer functionalized 
area as possible [30]. On the contrary, cells on mutant aptamer substrates (control group) 
maintained a globular shape. Such spreading and flatness of cancer cells on aptamer 
surfaces have been proven to be a potential modality for discrimination of cancer cells 
from healthy cells [152]. Similarly, on anti-EpCAM functionalized surfaces in our case, 
PC3 cells also spread well due to the intense interactions between antibodies and 
receptors; cells gradually spread onto the substrate which was facilitated by the newly 
generated affinity bonds at the contact edge of cell-substrate. In the other scenario of 
planar wafers, cells have to develop micron-scale focal adhesions independently; NPs 
with high aspect ratio might fail to provide sufficient areas for development of focal 
adhesion and thus cell spreading was inhibited on bare NPs. It was also noted that cells 
on NP550 showed larger aA  with smaller height compared to that on NP200. We 
speculated that it might be due to the complementary size match between the diameter of 
NPs (550 nm) and focal complex (generally with size around 500 nm), although the exact 
mechanism behind this phenomenon is still unknown. 
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Figure 4-5 Capture yield in terms of different apparent contact area. 
Finally, we studied the formation of subcellular adhesion structures under shear 
flow. It was observed that the formation of pseudopodia under shear is closely correlated 
with cellular adhesion status, shear force and shear direction. Figure 4-6(a) and (b) show 
a schematic of the experimental setup and locations of each wafer substrate 
corresponding to (c)-(i). We first examined cell behaviors on anti-EpCAM functionalized 
planar wafers at shaking speeds of 0, 60 and 400 rpm for 10 minutes after one hour of 
incubation. When shear force increases, a continuous transition of cell behaviors is 
observed, from being intact, dominant expression of lamellipodia to significant formation 
of filopodia (Figure 4-6(c)-(e)). Next, we examined cell behaviors on NP substrates by 
exertion of the same shear force (60 rpm for 10 min) on captured cells. Lamellipodia 
were more frequently observed in NP120 and NP200 cases (Figure 4-6(f) and (g)) where 
the total adhesion force between the substrate and cell is relatively large, while filopodia 
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were dominant in NP500 and NP1100 cases (Figure 4-6(h) and (i)) where adhesion force 
is relatively small. Based on these results, we speculated that the final formation of either 
lamellipodia or filopodia depends on the relative strength of cell adhesion force and 
applied shear force. Under shear force, cells were inclined to roll on the substrate; the 
larger the shear force, the greater the effect until final detachment. In our case, during the 
eluting process these unwashed cells are inclined to form new adhesive bonds at the 
leading edge and dissociate old ones at the trailing edge [153]. If the adhesive force 
generated between the cell and substrate is much larger than the applied shear force (cells 
on NP120 and NP200 substrates; cells on planar surface washed by 60rpm), the flowing 
fluid just gently aligns cells in the flow direction, and cells have sufficient time to form 
lamellipodia. In comparison, attached cells with less adhesion force in NP500 and 
NP1100 cases or suffering large shear force on planar surface are more susceptible and 
easier to roll on the surface. These cells develop filopodia during such dynamics, which is 
in agreement with a previous study showing that filopodia primarily acted as the traction 
force during spreading on a microstructured pattern [141]. It was also observed that the 
direction of the formation of lamellipodia and filopodia matched with the flow direction 
induced by shaking in Figure 4-6(b), indicating that lamellipodia and filopodia formed 
initially in the leading edge, which is in agreement with a previous study [154]. These 
findings indicate the possibility to control the formation of pseudopodia type and 
direction by applying shear force on attached cells. 
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Figure 4-6 Schematics of experimental setup and SEM images showing the cell-NP 
interactions (lamellipodia and filopodia) for different NP substrates. (a) A schematic of 
the experimental setup during shaking. (b) shows the corresponding locations on wafer 
substrates for (c)-(i), with corresponding flow directions marked in red arrows. (c)-(e) 
show cell behaviors on planar wafers with shaking speeds of 0, 60 rpm and 400 rpm, 
respectively. (f)-(i) show cell behaviors in NP120, NP200, NP 550 and NP1100 with an 
average spacing of 140 nm, respectively. Typical lamellipodia and filopodia are 
annotated in each figure. Orientations of (c)-(i) have been adjusted to be the same as that 
in (b). 
 
4.4 Conclusion 
 In summary, we found a linear relationship between capture yield and effective 
contact area of NP substrate with diameter ranging from 120 to 1100 nm. NPs with 
smaller diameter are preferred to achieve higher capture yield due to their large effective 
contact area. On the other hand, very small spacing below 100 nm (typically size of 
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microvilli) significantly impairs the capture yield. The effect of shear force on cell 
behaviors on an NP substrate was also studied for the first time. We found that the 
formation of filopodia or lamellipodia depends on the adhesion status of the captured cell, 
eluting strength and its direction. These findings provide guidance on the design of NP 
geometry for efficient CTC isolation, and possibilities to tune cytomorphology by 
manipulating shear forces.   
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Chapter 5: Hierarchical Micro-
/Nanostructured CTC Chip 
 
5.1 Introduction 
 Tumor is among the leading causes of deaths over the world. Tumor detection 
especially in the early stage is of great interest to both researchers and clinicians. 
Traditionally imaging techniques like MRI were mainly used to guide doctors to suspect 
a cancer occurrence while the cancer confirmation was still in need of an invasive biopsy 
[155]. However, the discomfort and a higher risk of infections brought by most invasive 
biopsies lays a hurdle for a general acceptance. Recently, liquid biopsy due to its intrinsic 
property of non-invasive attracts lots of attention and emerges as an appealing approach 
to diagnose cancers. A few biomarkers in blood have been recognized to detect cancers 
[156-159] such as circulating tumor cells (CTCs), which are the tumor cells originated 
from the primary tumor and circulating in the blood vessel during metastasis. Recent 
studies have revealed its clinical relevance in regards of both early cancer detection [47] 
and cancer prognosis [160-161], which directly correlates to the amount of CTCs per mL 
blood. However, the challenge to detect CTCs lies in its rarity, i.e. 1-100 per 1 mL blood 
vs. millions or billions of other normal blood cells. Various techniques have been 
developed to overcome the challenge. Currently, the detection techniques can be divided 
into two categories: physical property (e.g. size [162-163], dielectricity [37, 164] and 
deformability [165-166]) based and immunoaffinity (i.e. various antigen-antibody bonds 
[34-35, 86]) based approaches. Among the immunoaffinity based approaches, there exist 
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two categories based on the targeting cells, i.e. positive isolation [34-35] which targets at 
CTCs and negative isolation which depletes [167-168] white blood cells (WBCs). 
Although promising results with high capture efficiency have been achieved in various 
platforms [34-35, 55], it is still in need of a platform which can achieve both high capture 
efficiency and purity, which reflects the specificity among the isolated cell pool. 
 The emerging techniques of microfabrication and nanofabrication allow for a 
possibility to design various smart structures to enhance these device performance. A 
hallmark microfluidic device with grooved herringbone (HB) structures, initially 
proposed by Stroock et al. [56], was developed to efficiency isolate CTCs with a capture 
efficiency up to 93% and a purity of 14%. This HB design was mainly designed in use of 
stretched and disturbed flow streamlines which thus increase cell-surface interactions. 
Various derivatives of the HB chip [55, 78] were also developed but with similar 
grooved-HB structures. However, one main limitation on the grooved-HB chip lies in the 
extremely low shear rate regions in the groove troughs where WBCs are also readily 
trapped, thus might sacrificing the purity performance. To overcome this challenge, our 
group has recently developed a wavy-HB chip which smoothes the sharp groove 
structures thus eliminating the extremely low shear rate regions. The wavy-HB chips 
showed a capture efficiency up to 85% and a purity up to 39.4%. To further improve the 
device performance, various strategies have been proposed in literature by integrating 
nanostructures, which enhance the cell-surface interactions by increasing overall surface 
areas. For example, Tseng's group developed a few microfluidic chips which combine the 
herringbone microstructures with various nanostructures including nanopillars [54] and 
nanovelcro structures [59]. These hierarchical micro/nanostructures presented a better 
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capture efficiency of ~ 87% and their clinical utilities were also demonstrated on patients 
of various cancer phenotypes [59-60, 95]. Furthermore, the integration of nanopillars can 
be optimized following a design guide unraveled in our previous work [68], which 
suggested nanopillars with a diameter of 100 nm were preferred for enhanced CTC 
capture due to their large effective surface contact area.  
 In this study, a CTC chip with micro wavy-HB structures coated with 
nanoparticles (NPs) was developed with a high capture efficiency up to ~98% and a low 
non-specific capture of WBCs of ~680/mL blood. This hierarchical structures reflect 
combinative advantages from both microscale and nanoscale: by constructing the micro 
wavy-HB structures, the chip preserves a high purity by eliminating the extremely low-
shear regions; by integrating NP nanostructures, the chip presents a high capture 
efficiency due to both HB induced vortex effect and NP induced enhanced cell-surface 
interactions. As follows, the working mechanism of the microfluidic chip was first 
described. Then, the fabrication approach was introduced to integrate micro wavy-HB 
structures and NPs followed by an SEM characterization. Finally, the tumor cell capture 
test was performed on the developed CTC chip and results were compared with other 
designs in literature. 
5.2 Method and Materials 
5.2.1 Fabrication and Surface Functionalization of the Hierarchical 
CTC Chip  
 The hierarchical micro/nanostructured microfluidic chip was fabricated in two 
steps. First, a PMDS slab with micron wavy-HB structures was made by using the 
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previously developed reflow process [54]. Briefly, an SU8 master with traditional 
grooved-HB was first fabricated, followed by a replication of PDMS molds. A second 
SU8 master was then replicated by pressing the PDMS mold on an uncured photoresist 
layer. After removing the PDMS mold, the sharp grooved-HB structures were melted into 
wavy-HB structures by increasing the temperature. The fabricated SU8 master was then 
silane treated and used for PDMS replications. Another PDMS cover layer was also made 
through the traditional photolithography method, followed by punching holes for the inlet 
and outlet. 
 To deposit NPs on the wavy-HB structures, a layer-by-layer deposition approach 
was developed which utilized the electrostatic interaction between oppositely charged 
polymers[169], as shown in Figure 5-1. First, negative charges were introduced to the 
surface of the above-mentioned PDMS slab with wavy-HB structures by a plasma 
treatment. The PDMS slab was then immersed in a 0.01 mol/L Polyarylamine 
hydrochloride (PAH) solution for 5 mins to form a layer of positively charged polymers 
followed by a rinse with DI water. Negatively charged silica NPs with a diameter of 100 
nm were deposited by immersing the PDMS slab in 1% NP solution in ethanol for 5 s. To 
control the deposition consistency for each deposition, an automated manipulator was 
used to fix the pulling velocity at 5 mm/min [170]. The deposited PDMS slab was dried 
overnight under an enclosed environment of ethanol to reduce the evaporation induced 
convection effect, which could lead to a non-uniform particle coating [171-172]. The 
micro/nanostructures were then characterized by SEM scanning. Lastly, the hierarchical 
micro/nanostructured PDMS slab was assembled with the PDMS cover layer to make a 
microfluidic chip. 
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 For cancer cell capture test, microfludic chips were chemically functionalized 
with anti-EpCAM following a standard protocol [54]. Briefly, 3-mercaptopropyl 
trimethoxysilane (MPTS) was covalently linked with the hydroxyl group on the PDMS 
surface induced by plasma treatment. N-y-maleimidobutyryloxysuccinimide ester 
(GMBS) was then connected with MPTS, followed by a coating of NeutrAvidin. Within 
4 hrs of cell capture test, biotinylated anti-EpCAM was introduced to the microfluidic 
device. Regions uncovered with anti-EpCAM were blocked with BSA molecules which 
resist non-specific cell captures.  
5.2.2 Cell Sample Preparation and Capture Test 
 In this study, HCT-116 cells were used to model CTC performances for patients 
with colon cancer. Cells were cultured following a standard protocol by routinely 
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Figure 5-1 (a) The flow chart of NP deposition on the wavy-HB PDMS device. (b) 
The experimental setting for NP deposition. The PDMS device moves up and down 
following the needle which is controlled by the manipulator. 
(a) 
(b) 
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changing fresh cell medium comprised of Dulbecco’s Modified Eagle’s Medium, 1% 
penicillin/streptomycin antibiotics and 10% fetal bovine serum. Upon their confluency of 
70-80%, cells were diluted 103-105 /mL in either 4 mg/mL alginated PBS buffer solution 
or healthy whole blood purchased from Innovative Research. 
 Cell solution was injected into microfluidic chips at prescribed flow rates ranging 
from 580 μL/hr to 3600 μL/hr, which covers the widely used range in literature [35, 76]. 
PBS buffer solution was injected right after cell capture test to remove all suspended cells, 
followed by a fixation process by 4% paraformaldehyde. To further fluorescently identify 
captured cells, cells were treated with 0.2% Triton X-100 and further stained with a 
cocktail solution of DAPI, anti-cytokeratin FITC and CD45 PE. Cells which were DPAI 
positive, cytokeratin positive and CD45 negative were treated as tumor cells, while cells 
which were DAPI positive, cytokeratin negative and CD45 positive were treated as 
WBCs. Meanwhile, only cells with morphology integrity were counted. 
 To identify cell viability, a cocktail solution containing calcein-AM and ethidium 
homodimer (EthD-1) was used to perform a LIVE/DEAD assay. Cells were treated as 
viable if they were calcein-AM positive and EthD-1 negative, while all others were 
treated as dead. 
5.3 Results and Discussions 
5.3.1 Working Mechanism 
Deriving from the wavy-HB chip developed earlier by our group [54], the 
hierarchical CTC chip mainly improves the device performance by depositing NPs on the 
wavy-HB pattern, as shown in Figure 5-2(a). As a proof-of-concept study, the geometry 
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of the wavy-HB pattern was designed as the same in the previous work [35], where 
wavelength is 160 μm, wave amplitude is 22.5 μm, short/long arms are 100 μm/200 μm, 
intersection angle of short/long arm is 90° and channel height is 50 μm. Based on the 
geometry guide of nanostructures to optimize cancer cell capture [68], NPs with a 
diameter of 100 nm were used. 
 
From both numerical and experimental point of view, high capture efficiency can 
be achieved based on the wavy-HB pattern, which was demonstrated to induce significant 
vortex effect and own enlarged cell-surface contact area. Since the NPs have a diameter 
of 100 nm which is around 1/500 of the micropattern, the NP existence rarely influences 
the flow domain. Furthermore, the integration of NPs allows for an increase of cell-
surface interaction area due to the large surface-to-volume ratio for NPs. Assuming a 
Figure 5-2 (a) Concept illustration of cancer cell capture in a microfluid chip with 
hierarchical micro/nanostructures. NPs coated with anti-EpCAM are deposited on the 
wavy-HB pattern. (b) Photographic image of the test setting for the hierarchical CTC 
capture chip. 
Nanoparticle
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RBC
WBC
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Flow
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monolayer of NPs of 100 nm diameter are formed over the wavy-HB pattern, a 2-fold 
increase of surface area is achieved on the nanostructured surface. The increased surface 
area thus enhances cell-surface interactions and cell capture. On the other aspect, high 
purity can be achieved based on the smooth wavy pattern, which was demonstrated to 
eliminate the extremely low shear rate regions. The increased surface area rarely leads to 
an increased amount of WBCs as the non-specific areas are blocked by BSA buffer 
solution. 
5.3.2 Characterization of Hierarchical Micro/nanostructures 
 As shown in Figure 5-2(a), the PDMS slab needs to be dried after withdrawing it 
from the particle solution. It was noticed that if directly exposed in air and dried 
overnight, NPs were always distributed non-uniformly with more in the top ridge and less 
in the bottom trough as shown in Figure 5-3(a) and (b). This was explained by the fact 
that the thin fluid film underwent a convection flow induced by evaporation which 
brought NPs from the trough to the ridge [171-172]. In other words, the ethanol film 
evaporated fast in the ridge as it was thin compared to that in the bottom. As a result, it 
triggered a convection flow with NPs from the trough to the ridge. To reduce this effect, 
the PDMS slab was dried in a petri dish containing a small amount of ethanol solution, as 
shown in Figure 5-4(a-b). Although it increased the time for the drying process, the 
vapors from the ethanol pool sustained a humidity which reduced the above-mentioned 
evaporation induced convection effect. It thus formed a relatively more uniform coating 
of NPs over the whole wavy-HB pattern, as shown in Figure 5-4(c-d). 
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Figure 5-4 (a) Illustrative image of the NP deposition under the (b) improved 
evaporation setting. SEM images of deposited NPs on (c) top ridge and (d) bottom 
trough after the deposition process. 
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Figure 5-3 SEM images of deposited NPs on (a) top ridge and (b) bottom trough after 
the deposition process. (c) Illustrative image of the NP convection induced by ethanol 
evaporation if exposed directly to air. More particles are thus deposited on the top ridge 
and less particles on bottom trough. Scale bar: 2 μm. 
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5.3.3 Cancer Cell Capture Test 
 To evaluate the device performance, HCT-116 cancer cells were spiked into both 
PBS buffer solution and healthy whole blood. After the cell capture test, a standard 
fluorescent staining protocol was used to differentiate captured cancer cells and WBCs, 
which were then counted to calculate the capture efficiency and purity. Typical 
fluorescent images of captured cancer cells and WBCs are shown in Figure 5-5(a-d). 
Furthermore, it was also noticed that the hierarchical wavy-HB chip was able to capture 
both single cancer cells and cell-cell clusters, which were shown to be more correlated to 
cancer prognostics [161]. More cell-cell clusters were observed to be captured in the 
hierarchical wavy-HB chip compared to the pure wavy-HB chip (data not shown).  
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Figure 5-5 (a)-(d) Fluorescent images of a single cancer cell and a single WBC by 
using a cocktail solution containing DAPI, Cytokeratin-FITC and CD45-PE. (e)-(h) 
Fluorescent images of a single cancer cell and a two-cancer cell cluster by using the 
same cocktail solution. 
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 Capture efficiency of cancer cells in the hierarchical wavy-HB chip was 
compared to that in the pure wavy-HB chip, the grooved-HB chip and the flat chip, as 
shown in Figure 5-6(a). The overall trend of capture efficiency over shear rate in the 
hierarchical wavy-HB chip agrees well with that for both grooved-HB chip and pure 
wavy-HB chip, which is mainly due to the increased shear detachment force at high shear 
rate. However, it was noticed that the hierarchical wavy-HB chip outweighs other two 
kinds of microfluidic chips in capture efficiency. Especially at higher shear rate, i.e. 400/s, 
the enhancement reaches up to around 2 times (77.18% vs. ~30%). This enhancement 
was speculated from the increased total surface area brought by the integration of NPs, 
which agrees well with the findings in other works in literature [90, 173]. Interestingly, 
Figure 5-6(b) shows that the amount of non-specifically captured WBCs was similar 
between the pure wavy-HB chip and the hierarchical wavy-HB chip, which suggests that 
the integration of NPs does not lead to more non-specific WBC capture. Although the 
exact mechanism was not known yet, this consistent purity performance was speculated 
due to the fact that the non-specific bond force was smaller than the flow detachment 
force over the whole flow domain in both chips which eventually yielded a similar 
performance on WBC capture. Based on results shown in Figure 5-6(a-b), the 
hierarchical wavy-HB chip can lead to best capture efficiency among these chips. 
Meanwhile, if post-analysis like DNA analysis is needed where both high capture 
efficiency and high purity are required, the hierarchical wavy-HB chip can serve as a 
suitable candidate to be tested at high shear rates like 200/s and 400/s.  
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 Figure 5-7(a) shows a typical microscopic image of captured cancer cells in the 
hierarchical wavy-HB chip. Furthermore, SEM images were taken to reveal the details 
including cell morphologies and cell-surface interactions, as shown in Figure 5-7(b-c). 
These images again confirm that NPs sustained on the wavy-HB pattern after cell capture 
test. The apparent contact area was calculated to be around 101.7 μm2. By comparing it to 
that in our previous study [68] where cells were incubated for one hour, it is similar to the 
value (~110 μm2) where cancer cells spread on the bare wafer surface and smaller than 
that (~280 μm2) on the 120 nm NP arrays. But it is with expectation since the one-hour 
incubation allows cancer cells to spread over the substrate while in this study, cancer 
cells were fixed right after the cancer cell flow test. With the increased effective contact 
area due to the NPs, cancer cells were able to be captured more effectively compared to 
the bare wavy-HB surface. 
Figure 5-6 (a) Capture efficiency vs. shear rate in different devices in both PBS 
buffer solution and blood. (b) Amount of non-specifically captured WBCs in 1 mL 
blood in different devices at different shear rates. 
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 Another facile approach to fabricate hierarchical micro/nanostructures was also 
developed and tested in both flat channel and wavy-HB chip. The working mechanism 
was based on hydrophobic forces between two hydrophobic molecule groups. In detail, 
the PDMS surface after plasma treatment could recover to the hydrophobic condition if 
exposed to air for 24 hours. Meanwhile, the streptavidin coated magnetic microparticles 
used in this work are also hydrophobic due to the hydrophobic streptavidin molecules. As 
a result, after the injection of these microparticles through microfluidic chips, 
microparticles were subjected to adhesion over the whole PDMS surface due to the 
hydrophobic forces. As a proof-of-concept study, the particle coating performances were 
examined in both flat channel and wavy-HB chip in Figure 5-8(a) and (b), respectively. 
After PBS buffer flushing at 400/s, all particles were preserved which suggests that this is 
a facile and robust approach to deposit particles to form hierarchical micro/nanostructures. 
Furthermore, particle concentration could be adjusted to tune the coating density (data 
not shown here). 
Figure 5-7 (a) Microscopic image of captured cancer cells on the hierarchical wavy-
HB pattern. Scale bar: 160 μm. (b) SEM image of captured cancer cells on the pattern. 
Scale bar: 50 μm.  (c) The zoom-in image reveals details of the interaction between a 
cancer cell and the NPs covered wavy pattern. Scale bar: 8 μm. 
(a) (b) (c) 
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5.4 Conclusion 
 A microfluidic CTC isolation chip with hierarchical micro/nanostructures were 
developed. By extending the concept of previously developed wavy-HB chip, the 
integration of nanoparticles enhanced CTC capture due to the increased overall surface 
area. A previously developed particle deposition approach was used to fabricate the 
hierarchical patterns. In comparison to the pure wavy-HB chip and the hallmark grooved-
HB chip, the wavy-HB chip with hierarchical micro/nanostructures demonstrated a 
capture efficiency up to almost 100% at low shear rate (i.e. 60/s) and a high purity 
performance (only ~680 WBCs per 1 mL blood). SEM images were also used to further 
characterize the interaction between captured cancer cells and micro/nanostructures. 
Lastly, a facile approach was introduced to deposit micro/nanoparticles on the wavy-HB 
pattern and the feasibility was validated through a SEM characterization. 
  
Figure 5-8 Particle deposition after a single flush of streptavidin coated magnetic 
microparticles in (a) a flat channel and (b) a wavy-HB chip to form a hierarchical 
micro/nanostructures. Scale bar: 100 μm. 
(a) (b) 
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Chapter 6: Cancer Cell Capture and 
Release Assisted by Magnetic Particles 
in Hierarchical Wavy-HB Microfluidic 
Devices 
 
6.1 Introduction 
 Circulating tumor cells (CTCs) are originated from the primary tumor site and 
circulate over the course of metastasis. CTCs were among the several general cancer 
biomarkers which could be used for cancer detections [47] and cancer prognostics [160-
161]. Various techniques were thus developed to isolate CTCs in recent decades, which 
were categorized into either positive CTC isolation [35, 54, 59] or negative leukocytes 
depletion [167-168]. In other words, these techniques were either based on physical 
property differences or immunoaffinity differences between CTCs and normal blood cells 
including both red blood cells (RBCs) and white blood cells (WBCs). For example, based 
on the fact that CTCs uniquely express epithelial cell adhesion molecules (EpCAM), 
Toner's group developed a few microfluidic chips coated with corresponding antibody, i.e. 
anti-EpCAM, to capture CTCs [34-35]. The device performance was examined on 
various cancer types and demonstrated with a high capture efficiency of ~85%, which 
was essential for further clinical utility [174-175]. In these approaches, CTCs captured in 
the microfluidic chip were subjected to fluorescent staining and then imaged/counted 
through microscopic analysis. Besides the in-situ CTC analysis, there was a need for 
isolated CTCs to be collected and re-cultured which allows for further drug screening and 
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treatment guidance [55, 92, 176]. This in turn required isolated CTCs to be released from 
the capture bed. A few attempts were made by implementing stimulated subjects such as 
aptamers [86, 177] and thermo/PH-responsive materials [178-179]. An alternative which 
was currently widely studied was to use magnetophoresis to isolate either CTCs or WBCs 
labeled with corresponding immunomagnetic particles [180-183]. 
 Toner's group developed a CTC-iChip which first depleted RBCs based on 
deterministic lateral displacement and then negatively extracted all WBCs labeled with 
immunomagnetic particles by applying a magnetic field [181]. Similarly, Liu et al. [184] 
developed a microfluidic chip embedded with nickel micropillars, which positively 
isolated CTCs labeled with anti-EpCAM coated magnetic particles under a magnetic field. 
Although these techniques advanced CTC post-analysis, further improvements mainly lie 
in a development of a platform with high capture efficiency, high release efficiency and 
easy fabrication/operation modality. Our group previously developed a microfluidic chip 
with hierarchical micro/nanostructures for CTC capture with high capture efficiency and 
high purity [54, 68]: high capture efficiency was mainly attributed from the HB structures 
induced vortex effect and further enhanced by the nanostructures; high purity was 
achieved by smoothing the sharp grooved patterns into wavy patterns, thus eliminating 
the low-shear regions where WBCs were subjected to non-specific capture. Here, by 
extending this platform, instead of permanently depositing particles through 
immunoaffinity, anti-EpCAM coated magnetic particles were trapped over the untreated 
PDMS surface by external magnetic field and were then released by readily removing the 
magnet for CTC collection. 
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 In the following content, the working mechanism of the magnetic particle assisted 
cancer cell capture and release was first introduced. Various magnets settings were 
examined to find out the optimized condition. As a proof-of-concept, flow cytometer 
analysis was used in this work to evaluate the device performance. Finally, captured 
cancer cells labeled with magnetic particles were collected and re-cultured in regular 
petri-dishes to demonstrate the capability for further drug screening. 
6.2 Experimental Details 
6.2.1 Working Mechanism 
 The whole process was divided into three steps: magnetic particle trapping, cancer 
cell capture and subsequent cell release. First, 5 μL Stock solution of super-paramagnetic 
particles coated with streptavidin with a diameter of 1 μm was mixed with 95 μL 10 
μg/mL anti-EpCAM in BSA/PBS solution, followed by an incubation at RT for 2 hrs. 
This particle solution was then injected into the microfluidic chip at a flow rate of 3 
mL/hr for 2 mins. After stand-by for 5 minutes, the microfluidic chip was incubated 
under the magnetic field for 2 minutes, which allows all magnetic particles to reach their 
stable conditions. With the magnetic sustained, a cancer cell capture flow test was 
performed, where all cancer cells were subjected to being captured on the anti-EpCAM 
coated magnetic particles and normal blood cells were flushed away, as shown in Figure 
6-1(a). Wavy-HB microstructures were integrated into the microfluidic chip instead of a 
flat surface, which were demonstrated to ensure high capture efficiency and high purity in 
our earlier work [54]. Finally, to release captured cancer cells, the magnets were removed 
and a PBS flush at a flow rate of 3 mL/hr was applied to collect both individual magnetic 
particles and cancer cells labeled with magnetic particles, as shown in Figure 6-1(b). 
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Collected cancer cells were characterized either through a standard fluorescent imaging 
approach or flow cytometer analysis. Further post-analysis such as cell re-culture for drug 
screening could also be done. A typical experimental setting was also shown in Figure 
6-1(c). The two spacers were used to fix the magnet-magnet distance for consistent 
experimental analysis, as well as to protect the microfluidic chip from deformation due to 
the strong magnet-magnet attraction force. 
 
6.2.2 Microfluidic Chip Fabrication and Magnet Settings 
 The wavy-HB chip was fabricated and assembled following the reflow process 
introduced in our previous study [54]. Briefly, a PDMS slab with grooved-HB pattern 
Figure 6-1 Illustration of working principles of magnetic particle assisted cancer cell 
capture and release. (a) Capture of cancer cells on the anti-EpCAM coated magnetic 
particles deposited on the surface under the magnetic field. (b) Release and collection 
of captured cancer cells and magnetic particles after the removal of the magnet. (c) 
Photographic image of a typical experimental setting of cancer cell capture under the 
magnetic field. 
(a) (b) 
(c) 
Magnetic particle w/ anti-EpCAM
RBC
WBC
Tumor cell w/ EpCAM
Removing the magnet Cell Release
Flow
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was first replicated from a corresponding silicon wafer. This PDMS slab was then used as 
a mold to replicate a SU8 master mold on another silicon wafer. Before curing the SU8, 
the SU8 groove patterns were melted to wavy patterns at a median high temperature, i.e. 
65oC. With this mold, PDMS slabs with wavy-HB patterns were replicated and 
assembled with another cover pattern. To avoid the non-specific binding of streptavidin 
coated magnetic particles on the PDMS surface, 3% BSA/PBS solution was injected and 
incubated for 30 mins to block the non-specific sites. Then anti-EpCAM modified 
magnetic particles were injected through the microfluidic chip and incubated under 
certain magnetic fields. To investigate magnetic particles' response on various magnetic 
fields, three magnet settings were considered: two parallel magnets crossing with the 
microfluidic chip, two parallel magnets parallel to the microfluidic chip and two magnets 
sandwiching the microfluidic chip, as illustrated in Figure 6-2(a-c). To be noted, the 
cubic magnets had the polar in the large area planes rather than the two thin ends, as 
marked in Figure 6-2(a-c). 
6.2.3 Cancer Cell Culture, Flow Test and Re-culture 
 HCT-116 colorectal cancer cells were used in this study as model CTCs. HCT-
116 cells were cultured in Dulbecco’s Modified Eagle’s Medium supplemented with 1% 
penicillin/streptomycin and 10% fetal bovine serum. Within one hour of cancer cell flow 
tests, HCT-116 cells were prepared upon their 70-80% confluency and its initial cell 
concentration was calculated by hemocytometer, followed by a dilution in either 4mg/mL 
alginated PBS solution or whole blood.  
 Cell solution was injected through the microfluidic chip at various shear rates 
ranging from 60 /s to 400 /s controlled by a syringe pump. After cell capture process, 
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magnets were removed and cancer cells were collected in a centrifuge tube by flushing 
PBS buffer solution at a flow rate of 3 mL/hr. To perform cell re-culture, collected cancer 
cells labeled with magnetic particle and individual magnetic particles were added to a cell 
culture flask. Meanwhile, cell culture medium was added to supply necessary nutrients. 
After 24 hrs' culture in the incubator, suspensions were removed, the flask was washed 
with PBS solution and refreshed with new cell culture medium. Then cancer cells were 
cultured following the regular protocol and monitored routinely. 
 A proof-of-concept flow cytometer analysis was performed on the collected cell 
samples. In this scenario, after cell capture process, cell membranes were permeabilized 
by 0.2% Trion X-100 and cytokeratin-FITC was used to specifically stain the cancer cells. 
Then all cells and magnetic particles were collected in a centrifuge tube and analyzed by 
BD FACSCanto II flow cytometer. 
6.3 Results and Discussions 
 Magnetic particles' response under various magnetic fields were examined, as 
shown in Figure 6-2. It was found that different magnet settings lead to vastly different 
magnetic particle distributions over the microfluidic chip. Magnetic particles tended to 
form tails along the magnetic field. Specifically, under the magnetic setting as shown in 
Figure 6-2(a), magnetic particles formed tails parallel to the flow direction which is 
almost the same direction of the local magnetic field. Same phenomenon also happens to 
the magnetic setting in Figure 6-2(b). Under the magnet setting in Figure 6-2(c), 
magnetic particles were sparsely distributed and the magnetic field was vertical across the 
microfluidic chip. Furthermore, although most particles were able to sustain in the 
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microfluidic chip under PBS flushing at various shear rates up to 200/s, particles tails 
were subjected to being shifted towards specific focused regions, which were determined 
by the flow domain, as shown in Figure 6-2(j). 
 
 Furthermore, the formation of tails was explained from the theoretical perspective 
which fundamentally lies in the dipole-dipole force induced by a pair of magnetic 
particles under the magnetic field. As shown in Figure 6-3(a), two magnetic particles 
were exposed to the magnetic field and each particle experienced a dipole-dipole force 
S
N
S
N
S
N
After 
Incubation
After 
flush
Magnet
Microfluidic chip
Figure 6-2 Various magnet settings and their corresponding magnetic particle 
response. (a)-(c) Three different magnet settings. (d-f) Response of magnetic particles 
under the magnetic field of (a-c) in 2 minutes, respectively. (g-i) Response of 
magnetic particles after PBS buffer flushing of 200/s under the magnetic field of (a-c), 
respectively. Scale bar: 250 μm. (j) Streamlines in a unit of wavy-HB patterns. Flow 
direction is from left to right. 
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(d) 
(g) 
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exerted by the other particle. To the reactive magnetic particle as depicted in Figure 
6-3(a), components of the magnetic force in the radial direction and tangential direction 
were calculated as follows [185], 
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where   is the magnetic susceptibility of the particle, B is the magnetic flux density, a is 
the radius of the particle, 0  is the permeability of space, R is the distance between two 
particles and   is the intersection angle between the magnetic field and the particle-particle 
radial direction. Since in this study   was the main factor to be examined, a simple 
normalization could be performed as follows, 
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 As shown in Figure 6-3(b), if   is smaller than 45o, the reactive particle experiences 
an attractive magnetic force and a tail is thus formed; if   is larger than 45o, the reactive particle 
experiences a repelling magnetic force and these two particles thus keep apart. On the other 
aspect, the reactive particle always experience a negative tangential magnetic force, which tries to 
pull the reactive particle to align in the magnetic field direction. The magnitude of this pulling 
force reaches a maximized value when   is equal to 45o.  
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 This magnetic dipole theory was able to explain the magnetic particle distribution in 
Figure 6-2(d-f) under different magnetic fields. Take magnetic setting in Figure 6-2(a) as an 
example. Before applying the magnetic field, all magnetic particles were uniformly distributed 
over the microfluidic chip. Under the magnetic field, following the theory explained above, each 
pairs of particles with a   smaller than 45o, they were subjected to forming tails along the 
magnetic field direction; whereas each pairs of particles with a   larger than 45o, they were kept 
apart. Upon their stable condition, tails were formed parallel to the magnetic particles, as shown 
in Figure 6-2(d).  Figure 6-2(e) could be explained in the similar way. Slightly different from 
these two magnet settings, magnetic field direction approximately always were vertical to the 
plane of magnetic particles, i.e.   was equal to 90 o. In this condition, all particles experienced a 
repelling force which kept them apart. 
 
 To reach a uniform particle coating thus reaching maximized cell-surface 
interaction, the magnet setting in Figure 6-2(c) was used for the proof-of-concept study. 
Magnetic particles' response to the flow under the magnetic field was further investigated. 
Figure 6-3 Theoretical analysis of dipole-dipole induced magnetic forces. (a) Illustrative 
image of two magnetic particles to form a dipole-dipole pair under the magnetic field. 
(b) Normalized magnetic forces in the radial and tangential directions in term of 
intersection angles. 
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As shown in Figure 6-4(a-c), at the flow rate of 3600 mL/hr, magnetic particles exhibited 
different responses in different locations, with more particles  sustained close to the edge 
of the magnets while less particles in the center section, as marked in Figure 6-4(e). This 
was mainly attributed to a competition between the external magnetic force (Fm) and the 
flow detachment force. The flow detachment force was similar in these three sections due 
to the similar flow field. However, Fm varied by following the governing equation as 
follows [71],
  
𝐹𝑚 = (𝒎 ∙ ∇)𝑩 = 𝜇0(𝒎 ∙ ∇)𝑯         (6-5) 
where 
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p
p p
V
D




m H  and H is the total magnetic field strength applied on the center 
of the magnetic particle, V is the volume of the magnetic particle, Dp is the 
demagnetization coefficient (Dp is equal to 1/3 for a sphere), p  is the susceptibility of 
magnetic particle.  
 The magnetic field contour was then studied through a COMSOL simulation as 
shown in Figure 6-4(f). The magnetic force on a magnetic particle along point A to point 
B, which mimics the location of the microfluidic chip, was then calculated following eqn. 
(6-5), as shown in Figure 6-4(d). It was found that components of magnetic force in both 
x and y directions reached the maximum close to the magnet edges, where most particles 
were sustained. Meanwhile, the magnetic force was extremely small even close to zero in 
the center section, where most particles were flushed away. 
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 Although a uniform particle coating was not achieved yet, a proof-of-concept 
work to demonstrate the concept of cancer cell capture and release was performed. A 
flow cytometer analysis was adopted to quantitatively characterize the collected samples. 
As shown in Figure 6-5(a-b), a control study was firstly performed to identify beads, 
cancer cells and other blood cells, which were determined by both size difference and 
fluorescence labeling. A cancer cell capture test was then performed. Since this was still a 
preliminary capture test work where the exact capture efficiency and purity was not 
studied yet, the feasibility of this approach was the focus of this work. From the results 
shown in Figure 6-5(c), cancer cells and beads were able to be counted through the flow 
cytometer analysis. Further study was planned to quantitatively investigate the 
performance of this approach. 
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Figure 6-4 (a)-(c) Typical magnetic particle distributions under flushing of PBS 
buffer solution in three relative locations to the magnets in the setting of (e). Scale 
bar: 200 μm. (d) Magnetic forces from point A to point B in (f) which mimics the 
location of the microfluidic chip. (f) Contour of the magnetic field in the setting of (e). 
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 The feasibility of re-culture of collected cancer cells was also investigated. The 
biofluidic sample containing both collected cancer cells and magnetic particles were 
cultured in a regular petri-dish. One day after the initial sample loading, both cancer cells 
and magnetic particles were settled down on the petri dish, as shown in Figure 6-6(a). 
Clearly, it was observed that cancer cells were labeled with multiple magnetic particles 
Figure 6-5 Flow cytometer analysis of collected samples: (a) Cancer cells stained 
with cytokeratin-FITC in PBS buffer solution; (b) Whole blood and (c) Cancer cells 
stained with cytokeratin-FITC mixed with anti-EpCAM coated magnetic particles. 
Here, (a) and (b) serve as control group to identify cancer cells. Data in (c) is the 
experimental result from capture and release of cancer cells assisted by coated 
magnetic particles. 
(a) (b) 
(c) 
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even particle clusters. To observe the particle change over the course of cell proliferation, 
a series of microscopic images continuously recorded, from day 1 to day 4, and then from 
passage 0 to passage 2, as shown in Figure 6-6(b-d). Interestingly, it was found that 
magnetic particles gradually disappeared during cell proliferation. The exact mechanism 
was not unclear yet, and further study was still needed to reveal this mechanism. 
  
6.4 Conclusion 
 A microfluidic platform was developed to efficiently capture and release cancer 
cells by integrating a previously developed wavy-HB pattern and anti-EpCAM coated 
magnetic particles. In addition to the concept of magnetic particle assisted cancer cell 
Passage 0: Day 1 P0-D4
P1 P2
Figure 6-6 Re-culture of collected cancer cells linked with magnetic particles and 
individual magnetic particles. (a)-(b) Cell re-culture on Day 1 and Day 4 for Passage 
0, respectively. (c)-(d) Cell re-culture for Passage 1 and Passage 2, respectively. Scale 
bar: 40 μm. 
(a) (b) 
(c) (d) 
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capture and release which were achieved by other platforms [180, 186], this platform was 
designed for achieving high capture efficiency and high purity which was brought by the 
wavy-HB pattern. A proof-of-concept study was performed to demonstrate its feasibility. 
Furthermore, to my knowledge, this was the first time to directly indicate magnetic 
particles were able to be self-removed during cell proliferation, which was very crucial 
for cancer cell post-analysis where any dirt should be eliminated. Further efforts will be 
put in a more comprehensive investigation of the performance of this approach, such as 
recovery rate and purity. 
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Chapter 7: Isolation of Rare Tumor 
Cells Using Adhesion Rolling in a 
Microfluidic Chip with Inclined Wavy 
Surfaces 
 
7.1 Introduction 
 Circulating tumor cells (CTCs) were recognized as the origin of metastasis in 
many cancers. These cells are rare in the bloodstream, and, if isolated, can provide details 
on the diagnosis of non-hematologic and epithelial cancers, along with furthering 
research on metastatic cancers and their origins. The ultimate goal in this field is to 
isolate CTCs from normal blood cells with a high efficiency, high purity and high 
viability [187]. Various technologies were developed which fell into two main categories: 
Physical property based [37, 162, 165] and immuno-affinity based approaches [34, 54, 
181]. Due to the complexity of cell biology, currently there is no definite method to 
achieve the above-mentioned goal yet. Most of the methods on the separation of CTCs 
from whole blood required complex blood processing [188] and usually require complex 
approaches to detach captured CTCs [55, 86], thus yielding a low viability [189]. As a 
result, there is an urgent need to develop a technique to isolate CTCs from blood samples 
in a convenient and reliable manner. 
 In literature, it was found that E-selectin was present on endothelial cells when 
chemotaxis of leukocytes (leukocyte migration) is needed [190]. The ligand-receptor 
attraction allows for the rolling of the leukocytes. This same interaction was noted with 
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tumor cells. The binding allows for metastasis of cancers. In a previous study, CTC 
rolling on E-selectin was compared to white blood cells (WBCs) [191]. The WBCs 
exhibited a stronger interaction with stable, more numerous bonds. Conversely, CTCs 
maintained a weak bond. By taking advantage of this adhesion force difference, I aimed 
to develop a novel microfluidic chip coated with E-selectin to isolate CTCs from normal 
blood cells. A smart geometry was designed with an inclined wavy pattern which first 
focused all cells towards one channel side due to the hydrophoretic flow effect [57, 192], 
and then guided CTCs and WBCs to different pathways due to different adhesion forces. 
 In the following contents, the working mechanism of the device was first 
discussed. Then our preliminary experimental results are used to support the proposed 
idea. 
7.2 Methods 
7.2.1 Working Mechanism 
The overall strategy to isolate tumor cell from normal blood cells was described 
below: by designing a microfluidic chip with inclined wavy patterns coated with E-
selectin, tumor cell spiked blood samples were injected through the chip and different 
cells either flow or roll along different pathways, as sketched in Figure 7-1(a) and 
explained in the following paragraphs. The experimental test system was shown in Figure 
7-1(b). As a proof-of-concept work, RBCs were lysed so that isolation of only WBCs and 
CTCs were tested. 
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To achieve the cell adhesive rolling based cell isolation mentioned above, the 
device performance was evaluated from two aspects. First, with the inclined wavy pattern, 
the flow presents velocity components in the cross-section as shown in Figure 7-2 (a). 
Due to the fluid mass conservation and the inclined wavy direction, a large looped flow 
pattern with a clockwise direction is formulated as shown in Figure 7-2(b). Regarding the 
forces exerted on flowing cells, cells experience same gravity force and buoyant force 
everywhere while drag forces exhibit different directions in different locations. With the 
fact that the density of both CTCs and WBCs is larger than that of the fluid medium, cells 
undergo an instable force balance and shift following the flow loop pattern, finally 
focusing at the interfaces where buoyant force and drag force balance with the gravity 
[57]. 
After cell focusing to one side of the channel, the subsequent cell isolation is 
achieve based on different adhesive force for CTCs and normal blood cells. As shown in 
Figure 7-2(c), it was found that RBCs have no interaction with the E-selectin coated 
Inlet
Outlet 1
Outlet 2
RBC 
WBC CTC 
Yz
X
(a) 
(b) 
Figure 7-1 (a) Experimental setup for the tumor cell isolation. (b) The proposed 
concept of different cells flowing or rolling along different pathways. 
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surface, thus following the straight flow stream. Both CTCs and WBCs perform adhesive 
rolling on E-selectin while stronger adhesion force exists for WBCs. In combination of 
the inclined wavy pattern which provides a guiding direction, it is expected that CTCs 
and WBCs will roll on E-selectin coated surface following different pathways. 
 
7.2.2 Microfluidic Chip Fabrication and Surface Functionalization 
A reflow approach was used to fabricate the inclined wavy pattern [54]. Briefly 
speaking, traditional grooved pattern was firstly fabricated as a master. After replicating 
Y
z(a) 
Figure 7-2 (a) The velocity contour in the cross-section of the Fig. 1(b). (b) A 
schematic image of the looped flow pattern and the forces on a flowing cell. (c) A 
schematic image indicates the interaction between cells and E-selectin coated 
surfaces. 
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an uncured photoresist mold by the nano-imprint approach, the photoresist was melt to 
form waves at 65 oC. PDMS devices were then replicated based on this SU8 mold and 
assembled into a microfluidic chip. 
A protocol was developed to coat E-selectin on the microfluidic chip referring to 
similar approaches [193-194]. Right after the assembly of the microfluidic chip, the 
device was incubated with 1% v/v APTES in ethanol for 30 minutes, followed by an 
enhancement in 100 degrees for 10 minutes. Then the device was modified with 10 
μg/mL of recombinant protein G in PBS, which was then linked with E selectin by an 
incubation of 20 μg/mL of recombinant human E-selectin/Fc-chimera for 2 hrs. Lastly, 
the device was blocked with 1% BSA for 60 minutes to avoid any non-specific bindings. 
7.2.3 Cell Culture and Isolation Test  
 PC3 prostate cancer cells were cultured and used as a model CTC cell line. Cells 
were cultured with F-12K growth medium supplemented with 10% FBS and 1% 
Penicillin/Streptomycin. The medium was regularly refreshed during cell proliferation 
and PC3 cells were used upon their confluency reaching 70-80%. Before cell isolation 
test, PC3 cells were pre-stained with cell-tracker and then spiked into human whole blood 
or RBC lysed blood. Cell solution was then injected into the E-selectin coated 
microfluidic chip. Regular and fluorescent microscopes were used to observe the cell 
rolling and isolation process. To quantify the cell rolling velocities, cell rolling process 
was recorded and then analyzed by ImageJ. 
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7.3 Results  
To demonstrate the focusing effect brought by the inclined wavy pattern, a cell 
flowing test in a microfluidic chip with no E-selectin coating was performed, as shown in 
Figure 7-3. It was clearly observed that all cells were focused to the side channel with a 
narrow focusing band, which was explained in Figure 7-2(b). This observation assures all 
cells to be first focused to one side and then to be isolated based on the adhesion force 
difference mentioned above. 
  
 To demonstrate the adhesion difference for PC3 cells and WBCs, a time series of 
cell rolling on an E-selectin coated flat surface for these two cells were recorded, as 
shown in Figure 7-4(a) and (b), respectively. Clearly, it indicates that PC3 cells roll faster 
than WBCs. A further quantitative analysis of cell rolling velocities for CTCs and WBCs 
under different shear rates and different coating densities was performed, as shown in 
Figure 7-4(c).  In comparison to WBCs, the larger rolling velocity for PC3 cells suggests 
a smaller adhesion force between PC3 cells and E-selectin. This supports our hypothesis 
Figure 7-3 Optical image indicates cell focusing effect in a microfluidic chip with 
inclined patterns.  
Flow direction
Focusing band
100 μm
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that PC3 cells and WBCs would be geared towards different pathways, as sketched 
Figure 7-1(a). 
 
7.4 Conclusion  
 Our preliminary results demonstrated the cell focusing effect and adhesive force 
difference in the proposed microfluidic chip coated with E-selectin, which suggests that 
the proposed cell adhesive rolling based approach for tumor cell isolation was feasible. 
This approach provides a convenient strategy to isolate tumor cells from whole blood 
without any blood processing and cell detachment operation, thus providing a convenient 
Figure 7-4 Transient cell rolling image for (a) CTC and (b) WBC. (c) Rolling velocity 
for PC3 cells and WBCs under different shear rates and different E-selectin coating 
density. 
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platform which is essential for tumor cell profiling and genomic analysis. Future work 
will be performed to validate the full functionality of this device. 
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Chapter 8: Summary and Outlook 
 
 This dissertation describes several techniques and platforms to advance the 
isolation of circulating tumor cells (CTCs), which were demonstrated to own significant 
clinical relevance in cancer early detection and cancer prognosis. Although various 
techniques were developed in literature to isolate CTCs, further improvements were still 
needed for device performances (such as capture efficiency, purity and viability) which 
were essential in producing an accurate and precise result towards precision medicine. 
Meanwhile, the advance of micro-/nano-techniques especially micro/nanofluidics brought 
lots of new approaches to solve the problems in biomedical field. Due to the nature of 
micro/nanofluidics such as low volume cost and fast reaction, traditional lab scale tests 
were scaled down to micro/nanoscale which was more fast and accurate. We were thus 
motivated to develop novel techniques based on micro-/nano-techniques to tackle the 
challenge of isolation of CTCs. Due to the heterogeneity of CTCs in size and 
deformability, it was noticed that CTCs of epithelial origin uniquely expressed EpCAM 
which allows for a specific CTC isolation based on an immunoaffinity approach. By 
realizing the fundamental difference between CTCs and other blood cells, we developed 
a microfluidic CTC isolation chip with wavy-HB patterns and optimized the design 
through a numerical geometric study. We then explored the effect of nanostructures in 
enhancing CTC isolation and developed another microfluidic chip with hierarchical 
micro/nanostructures by extending the previous design. Lastly, we made a few attempts 
to develop microfluidic platforms which allow for a direct collection of CTCs in free 
suspension, which was essential for off-chip CTC post-analysis. All these six projects 
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laid the ground for further integration of micro-/nano-techniques to tackle clinical 
practice. With the demonstrated results, we envision that the patient care especially 
cancer patient care would be advanced with the emerging liquid biopsy. 
 We first developed a microfluidic CTC isolation chip with wavy-HB patterns. By 
extending the hallmark grooved-HB chip proposed in Toner's group, we smoothed the 
sharp groove transitions into wavy patterns. This change eliminated extremely low shear 
rate regions in the groove troughs where WBCs were subjected to non-specific capture. 
Through a side-by-side comparison with state of the art grooved-HB chip, the wavy-HB 
patterns were demonstrated to present a better purity and viability performance, while 
preserve a high capture efficiency performance which was originally the main advantage 
of the grooved-HB chip. The wavy-HB chip was thus able to serve as a potential platform 
for clinical practice. Furthermore, this study does not only yield one single microfluidic 
chip, but also initiates a new strategy to improve the device performance by replacing the 
sharp groove patterns with smooth wavy patterns. This could be adopted to further 
improve many existed microfluidic platforms in literature. With the proof-of-concept 
work being established, a further optimization on HB structures for CTC capture was 
performed through a numerical study. By realizing the complex nature of ligand-receptor 
bond formation, we utilized a lumped parameter model to determine the adhesion 
probability through a few simple experimental tests. Then the modified CTC transport 
and capture model was used to optimize the HB structures in terms of various geometric 
parameters. We found that short arm ratio of 0.5 was optimized for tumor cell capture 
which is against 1/3 obtained from most studies in literature. This was mainly attributed 
to the bias of pure mixing effect on determining cell capture in most studies, while the 
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particulate cell transport was missing which was significantly important in CTC capture 
work.  
 By building on the foundation of the wavy-HB chip, we then explored the 
possibilities to integrate nanostructures to further enhance the CTC capture performance. 
To gain a better understanding of nanostructures on CTC capture, we investigated the 
geometric effects of nanopillars on capture efficiency with a focus on nanopillar diameter 
and spacing. It was found that CTC capture was optimized when nanopillars were smaller 
in diameter due to its larger overall effective contact area. Moreover, a linear correlation 
between capture efficiency and nanopillar diameter was unraveled which serves a guide 
for other researches to optimize their nanostructure platforms. 
 A microfluidic CTC isolation chip integrated with micro wavy-HB patterns and 
nanoparticles was then developed to aim at high capture efficiency and high purity 
performance. By combining the advantages brought by both wavy-HB patterns and 
nanostructures, the hierarchical micro/nanostructures were hypothesized to own a better 
device performance. We fabricated and assembled the device through a newly developed 
approach and then performed cancer cell isolation work by comparing the results with the 
state of the art. Significantly, the microfluidic CTC chip with hierarchical 
micro/nanostructures were demonstrated a higher capture efficiency and a similar purity. 
By pushing the device performance to another higher extreme, this platform indicates its 
capability to serve as a more effective platform for CTC isolation toward more 
demanding clinical practice. 
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 One main limitation in anti-EpCAM based CTC isolation approaches is that 
captured CTCs are firmly trapped on the capture bed which brings the difficulty to collect 
them for off-chip analysis. By noticing this limitation, several techniques were developed 
to collect CTCs through stimulated release [55, 86, 88, 184]. In this dissertation, we also 
made two attempts to collect CTCs in free suspensions: magnetic particle assisted CTC 
capture and release, and cell adhesion rolling based CTC isolation. For the first idea, the 
fundamental working mechanism was based on the fact that magnetic particles were 
subjected to trapping and releasing by tuning the external magnetic field. We extend our 
previously developed wavy-HB chip by integrating anti-EpCAM coated magnetic 
particles. As a result, the advantages of the hierarchical micro/nanostructures were again 
adopted, while CTCs were able to be collected due to the controllable magnetic particles. 
A proof-of-concept work was performed and the flow cytometer analysis revealed its 
feasibility of CTC capture and release. Furthermore, this platform also allowed for a re-
culture of collected CTCs and for the first time, we showed that the labeled immuno-
magnetic particles could be removed through a continuous cell proliferation. 
 By realizing the complex handling process of magnetic particle assisted CTC 
capture and release, the second idea allows the platform to be handled with only one-step 
biofluid injection. The working mechanism was explained which fundamentally relies on 
the adhesion rolling difference between CTCs, WBCs and RBCs on the E-selection 
coated surface. A microfluidic chip with inclined wavy pattern was designed and a proof-
of-concept work was performed to demonstrate its feasibility on CTC isolation in free 
suspension.  
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 These developed microfluidic chips offer an effective approach to isolate CTCs. 
However, it was also noticed that no such a platform was suitable for all applications 
based on a few factors. First, CTCs are highly heterogeneous in immuno-expression. 
Specifically, CTCs undergoing epithelial to mesenchymal transition were demonstrated 
to have a down-regulation of EpCAM, which suggests that the anti-EpCAM based 
approach might not be effective any more. Another heterogeneity is attributed to various 
phenotypes of cancer cells. As such, currently there was not a generic antibody which 
could form ligand-receptor bonds with all cancer cells. Second, it was noticed for most 
platforms, there was always a trade-off between capture efficiency and purity. Although 
various techniques were developed to boost these two factors together, there still existed 
drawbacks such as complex fabrication process and high cost, which impedes its 
application in a few conditions, especially in economy poor countries. With these 
limitations to be mentioned, a few approaches were proposed recently and could serve as 
a potential solution. For example, since CTCs were found to have a down-regulated 
EpCAM expression, a cocktail antibody solution containing anti-EpCAM and other well-
known biomarkers was used to enhance the CTC isolation [195-196]. Another alternative 
approach recently proposed by Toner's group is to isolate CTCs from a negative 
perspective. This approach was developed by realizing that CTCs were always 
heterogeneous while other blood cells were relatively well recognized. As a result, they 
developed a CTC-iChip which was negatively isolate RBCs and WBCs, thus only 
collecting CTCs [181]. 
 So far, various microfluidic platforms have been developed in different research 
groups and companies. Although more and more clinical samples were directly tested on 
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a few microfluidic chips, a significant amount of clinical trials are still needed to 
demonstrate their clinical feasibility. Moreover, from the clinical perspective of view, 
although a few clinical studies showed a strong clinical relevance between cancer 
metastasis and CTCs, more clinical studies are still needed to support this statement. 
Another topic which draws lots of attention in the CTC field is that since so many 
platforms for CTC isolation have been established with demonstrated good performance, 
what exactly can patients and doctors gain out of there? Debates and exploration are 
always going and being engineers we look forward to more clinical insights. 
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